Page last updated: 2024-12-05

juglone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Juglone, also known as 5-hydroxy-1,4-naphthoquinone, is a natural compound found in the roots, leaves, and hulls of walnut trees (Juglans regia). It exhibits a range of biological activities, including antimicrobial, antifungal, and insecticidal properties. Juglone is synthesized through a biosynthetic pathway involving the conversion of the amino acid tryptophan. It has been studied for its potential applications in agriculture as a natural pesticide and fungicide. Juglone's antifungal activity is particularly significant, as it has shown effectiveness against various plant pathogens. The compound's antimicrobial properties are attributed to its ability to disrupt microbial cell membranes and interfere with their metabolic processes. The potential of juglone as a natural pest control agent has generated significant interest in agricultural research.'

juglone: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

juglone : A hydroxy-1,4-naphthoquinone that is 1,4-naphthoquinone in which the hydrogen at position 5 has been replaced by a hydroxy group. A plant-derived 1,4-naphthoquinone with confirmed antibacterial and antitumor activities. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID3806
CHEMBL ID43612
CHEBI ID15794
SCHEMBL ID34185
MeSH IDM0046458

Synonyms (140)

Synonym
5-hydroxy-naphthalene-1,4-dione
nsc-622948
1, 8-hydroxy-
5-hydroxy-1,4-naphthalenedione
CHEBI:15794 ,
1,4-naphthalenedione, 5-hydroxy-
1,4-naphthoquinone, 5-hydroxy-
NSC34266 ,
nsc-34266
KBIO1_001026
DIVK1C_001026
SDCCGMLS-0066542.P001
nsc 622948
1,4-naphthoquinone, 8-hydroxy-
ccris 5423
5-hydroxy-1,4-naftochinon [czech]
brn 1909764
caswell no. 515aa
einecs 207-567-5
nsc 153189
SPECTRUM4_001769
SPECTRUM_000415
BIO2_000409
BIO1_001419
BIO1_000441
BIO2_000889
BIO1_000930
5-hnq
nsc622948
5-hydroxynaphthalene-1,4-dione
SMP1_000168
CMAP_000058
juglone
481-39-0
5-hydroxy-1,4-naphthoquinone
C03840
nci 2323
8-hydroxy-1,4-naphthoquinone
yuglon
5-hydroxy-1,4-naphthosemiquinone
juglon
nsc-153189
5-hydroxynaphthoquinone
c.i. 75500
c.i. natural brown 7
jugnlon
nsc153189
nucin
iuglon
juglane
regianin
akhnot
wln: l66 bv evj gq
inchi=1/c10h6o3/c11-7-4-5-9(13)10-6(7)2-1-3-8(10)12/h1-5,12
5-hydroxy-1,4-naphthoquinone, 97%
5-hydroxy-p-naphthoquinone
NCGC00095247-03
NCGC00095247-01
NCGC00095247-02
KBIO2_003463
KBIO3_000914
KBIO2_005038
KBIO3_002948
KBIO2_006031
KBIO2_002470
KBIO2_007606
KBIOSS_002477
KBIO2_005633
KBIOGR_002257
KBIOSS_000895
KBIO2_000895
KBIO3_000913
KBIO2_000497
KBIO3_002176
KBIOSS_000497
KBIO2_003065
KBIOGR_000497
KBIOGR_002470
SPBIO_000856
SPECTRUM2_000778
SPECTRUM3_001228
NINDS_001026
SPECTRUM300038
IDI1_001026
SPECTRUM5_000357
BSPBIO_002676
IDI1_002164
BSPBIO_001157
NCGC00095247-05
NCGC00095247-04
bdbm24777
chembl43612 ,
5-hydroxy-1,4-naphthoquinone, 4
5-hydroxy-1,4-dihydronaphthalene-1,4-dione
HMS1990I19
3B7J
5-hydroxy-[1,4]naphthoquinone
AKOS001576598
HMS503M13
HMS1362I19
HMS1792I19
H0286
HMS1923G07
A827478
CCG-40256
5-hydroxy-1,4-naftochinon
unii-w6q80sk9l6
4-08-00-02368 (beilstein handbook reference)
w6q80sk9l6 ,
FT-0627559
AM20040546
S5512
SCHEMBL34185
juglone [mi]
ci-75500
1,4-dihydro-1,4-dioxo-5-hydroxynaphthalene
8-hydroxy-1,4-naphthalenedione
J-650071
Q-100522
HMS3403I19
DTXSID0031504
mfcd00001684
sr-05000002406
SR-05000002406-1
5-hydroxy-1,4-naphthalenedione, 9ci
-hydroxy-1,4-naphthalenedione
ci 75500
antibiotic pd7
juglone - cas 481-39-0
F17689
F0451-0746
juglone crystallized
481-13-0
Q900912
ZB1862
CS-W017516
A936425
HY-N6949
EN300-160375
SY051453

Research Excerpts

Overview

Juglone is a phenolic bioactive compound with antimicrobial, antitumour, antioxidant, and anti-inflammatory characteristics. It has various pharmacological effects such as antiviral, antibacterial, and anticancer. Juglones significantly decreased DMN‑induced rat hepatic fibrosis.

ExcerptReferenceRelevance
"Juglone is a promising candidate for the development of a new environmentally friendly plant protectant to replace the antibiotic streptomycin currently used in fire blight control."( Potent and specific bactericidal effect of juglone (5-hydroxy-1,4-naphthoquinone) on the fire blight pathogen Erwinia amylovora.
Fischer, TC; Gosch, C; Gselmann, M; Mirbeth, B; Stich, K; Thallmair, V, 2012
)
1.36
"Juglone is a natural compound which has been isolated from Juglans mandshurica Maxim. "( Juglone, isolated from Juglans mandshurica Maxim, induces apoptosis via down-regulation of AR expression in human prostate cancer LNCaP cells.
Qu, S; Sui, D; Xu, H; Yu, X, 2013
)
3.28
"Juglone is a phenolic bioactive compound with antimicrobial, antitumour, antioxidant, and anti-inflammatory characteristics. "( Juglone Mediates Inflammatory Bowel Disease Through Inhibition of TLR-4/NF KappaB Pathway in Acetic Acid-induced Colitis in Rats.
Abdolghaffari, AH; Abdollahi, AR; Alizadeh Nobakht, NA; Esmaealzadeh, N; Khayatan, D; Lashgari, NA; Momeni Roudsari, N; Momtaz, S; Niknejad, A; Tavakoli, S, 2023
)
3.8
"Juglone is a metabolite produced by several species of plants, in particular Juglans nigra. "( Juglone: A Versatile Natural Platform for Obtaining New Bioactive Compounds.
da Rocha, DR; Dos S Moreira, C; Freitas, RHCN; Pacheco, PAF; Santos, TB, 2021
)
3.51
"Juglone is a natural pigment, which has cytotoxic effect against various human tumor cells. "( Juglone induces apoptosis of tumor stem-like cells through ROS-p38 pathway in glioblastoma.
Chen, L; Hua, W; Mao, Y; Wu, J; Xu, Y; Zhang, H; Zhang, J; Zhang, Y; Zhu, W, 2017
)
3.34
"Juglone is a natural compound isolated from walnut trees."( Juglone potentiates TRAIL‑induced apoptosis in human melanoma cells via activating the ROS‑p38‑p53 pathway.
Chen, Y; Ding, F; Du, J; Li, J; Liu, X; Liu, Y; Lv, Y; Mo, S; Wu, J; Zhang, Y, 2017
)
2.62
"Juglone is a natural compound which has been isolated from Juglans mandshurica Maxim, and it has various pharmacological effects such as antiviral, antibacterial, and anticancer."( Investigation of apoptotic effect of juglone on CCL-228-SW 480 colon cancer cell line.
Armagan, I; Bayram, D; Özgöçmen, M; Şenol, N; Sevimli, M; Türel, GY,
)
1.13
"Juglone, which is a quinone, significantly decreased DMN‑induced rat hepatic fibrosis, which was associated with increased superoxide dismutase (SOD) activity, decreased oxidative stress and reduced levels of α‑smooth muscle actin (α‑SMA) and collagen (Col) III in the liver."( Hepatoprotective effect of juglone on dimethylnitrosamine-induced liver fibrosis and its effect on hepatic antioxidant defence and the expression levels of α-SMA and collagen III.
He, S; Jiang, MD; Mu, D; Weng, M; Zeng, WZ; Zhang, Y; Zheng, SM; Zhou, DJ, 2015
)
1.44
"Juglone is a plant-derived 1,4-naphthoquinone with confirmed antibacterial and antitumor activities."( Antibacterial Activity of Juglone against Staphylococcus aureus: From Apparent to Proteomic.
Bai, B; Cheng, Y; Jiang, D; Sun, X; Tan, D; Wang, J; Wu, R; Wu, Z; Yan, T; Zhang, Q, 2016
)
1.46
"Juglone is a plant-derived 1,4-naphthoquinone with confirmed antibacterial activity. "( Proteomic Analysis of the Antibacterial Mechanism of Action of Juglone against Staphylococcus aureus.
Bai, B; Jiang, D; Sun, X; Tan, D; Wang, J; Wang, Z; Wu, R; Wu, Z; Yan, T; Zhang, Q, 2016
)
2.12
"Juglone is a phenolic compound used in popular medicine as a phytotherapic to treat inflammatory and infectious diseases. "( Actions of juglone on energy metabolism in the rat liver.
Bracht, A; Comar, JF; Mito, MS; Peralta, RM; Saling, SC, 2011
)
2.2
"Juglone is a substituent of walnut foliage."( Effects of juglone (5-hydroxy-1,4-naphthoquinone) on midgut morphology and glutathione status in Saturniid moth larvae.
Lindroth, RL; Thiboldeaux, RL; Tracy, JW, 1998
)
1.41

Effects

Juglone has been showed to exert a direct cytotoxic effect on tumor cells. The juglone-NaSe has the potential to be a promising agent especially to inhibit invasion and metastasis.

ExcerptReferenceRelevance
"Juglone has a promising potential to develop new strategies for the treatment of PC (Tab. "( Juglone can inhibit angiogenesis and metastasis in pancreatic cancer cells by targeting Wnt/β-catenin signaling.
Arikoglu, H; Erkoc-Kaya, D; Gokturk, F, 2021
)
3.51
"The juglone-NaSe has the potential to be a promising agent especially to inhibit invasion and metastasis in pancreatic cancer treatment. "( The effects of Juglone-Selenium combination on invasion and metastasis in pancreatic cancer cell lines.
Arikoglu, H; Avci, E; Dursunoglu, D; Kaya, DE, 2022
)
1.63
"Juglone has a promising potential to develop new strategies for the treatment of PC (Tab. "( Juglone can inhibit angiogenesis and metastasis in pancreatic cancer cells by targeting Wnt/β-catenin signaling.
Arikoglu, H; Erkoc-Kaya, D; Gokturk, F, 2021
)
3.51
"Juglone has been showed to exert a direct cytotoxic effect on tumor cells."( Juglone eliminates MDSCs accumulation and enhances antitumor immunity.
Cui, Y; E, F; Gao, X; Qiu, Z; Wang, H; Yu, Y; Zhang, H; Zhao, W; Zou, C, 2019
)
2.68
"Juglone has gained interest by the researchers for its anticancer properties."( Exploring the antiviral activity of juglone by computational method.
Vardhini, SR, 2014
)
1.4

Actions

Juglone can cause ultrastructural changes of human liver cancer BEL-7402 cells and induce their apoptosis. Only juglone was able to cause a fast depletion of plastoquinol, which may be an important mode of action.

ExcerptReferenceRelevance
"Only juglone was able to cause a fast depletion of plastoquinol, which may be an important mode of action of this allelochemical, responsible for its high toxicity to plants."( Impact of cytotoxic plant naphthoquinones, juglone, plumbagin, lawsone and 2-methoxy-1,4-naphthoquinone, on Chlamydomonas reinhardtii reveals the biochemical mechanism of juglone toxicity by rapid depletion of plastoquinol.
Barnaś, K; Dziuba, J; Kapsiak, M; Nowicka, B; Suchoń, A; Walczak, J, 2023
)
1.63
"Juglone could inhibit the growth of TSCs in gliomas through the activation of ROS-p38-MAPK pathway in vitro, and the anti-glioma effect was validated in vivo, which offers a potential therapeutic agent to gliomas."( Juglone induces apoptosis of tumor stem-like cells through ROS-p38 pathway in glioblastoma.
Chen, L; Hua, W; Mao, Y; Wu, J; Xu, Y; Zhang, H; Zhang, J; Zhang, Y; Zhu, W, 2017
)
3.34
"Juglone can cause ultrastructural changes of human liver cancer BEL-7402 cells and induce their apoptosis."( [Effect of juglone on the ultrastructure of human liver cancer BEL-7402 cells].
Chen, L; Gu, WW; Na-Shun, BY; Yu, J; Zhang, J, 2009
)
2.19

Treatment

Juglone pretreatment before radiation also resulted in a significant elevation in the intracellular reactive oxygen species levels compared with radiation alone. All juglone-treated groups reduced the NF-κB levels compared to the control group (p < 0.001). Jugl one treatments from 10 to 1000 microM significantly reduced H+-ATPase activity compared to controls.

ExcerptReferenceRelevance
"All juglone-treated groups reduced the NF-κB levels compared to the control group (p < 0.001)."( Juglone Mediates Inflammatory Bowel Disease Through Inhibition of TLR-4/NF KappaB Pathway in Acetic Acid-induced Colitis in Rats.
Abdolghaffari, AH; Abdollahi, AR; Alizadeh Nobakht, NA; Esmaealzadeh, N; Khayatan, D; Lashgari, NA; Momeni Roudsari, N; Momtaz, S; Niknejad, A; Tavakoli, S, 2023
)
2.83
"Juglone treatment significantly inhibited the protein levels of IL-6, TNF-α and IL-1β, improved the protein expression of IL-10."( Juglone regulates gut microbiota and Th17/Treg balance in DSS-induced ulcerative colitis.
Cui, L; Guan, X; Hua, Y; Liu, R; Lu, M; Tian, Y; Zhang, Z; Zhuang, S, 2021
)
2.79
"Juglone pretreatment before radiation also resulted in a significant elevation in the intracellular reactive oxygen species levels compared with radiation alone."( Tumor growth inhibitory effect of juglone and its radiation sensitizing potential: in vivo and in vitro studies.
Aithal, KB; Kumar, S; Rao, BN; Rao, SB; Udupa, N, 2012
)
1.38
"In juglone-treated cells, ascorbate increased ROS formation (4-fold) and depleted GSH (65%)."( Inhibition of cell proliferation and migration by oxidative stress from ascorbate-driven juglone redox cycling in human bladder-derived T24 cells.
Benites, J; Buc Calderon, P; Farias, MS; Felipe, KB; Glorieux, C; Kviecinski, MR; Pedrosa, RC; Sid, B; Valderrama, JA; Valenzuela, M; Verrax, J, 2012
)
1.11
"Juglone treatments from 10 to 1000 microM significantly reduced H+-ATPase activity compared to controls."( Juglone disrupts root plasma membrane H+-ATPase activity and impairs water uptake, root respiration, and growth in soybean (Glycine max) and corn (Zea mays).
Hejl, AM; Koster, KL, 2004
)
2.49
"Juglone-treated rats showed a dramatic reduction (approximately 75%) in bronchoalveolar lavage fluid and pulmonary eosinophilia but no change in lymphocyte, monocyte/macrophage, or neutrophil numbers. "( A critical role for Pin1 in allergic pulmonary eosinophilia in rats.
Esnault, S; Malter, JS; Rosenthal, LA; Sedgwick, JB; Shen, ZJ; Sorkness, RL; Szakaly, RJ, 2007
)
1.78
"In juglone-treated explants, GSSG increased 2.1 and 5.6-fold, respectively, for A."( Effects of juglone (5-hydroxy-1,4-naphthoquinone) on midgut morphology and glutathione status in Saturniid moth larvae.
Lindroth, RL; Thiboldeaux, RL; Tracy, JW, 1998
)
1.2
"Treatment with juglone significantly lowered c-Myc protein expression in HeLa cells in a concentration-and time-dependent manner ("( [Juglone induces proliferation inhibition and apoptosis of cervical cancer cells
He, H; Song, Z; Yang, K; Zhang, W; Zhao, X, 2022
)
1.98
"Treatment with juglone was not as effective as with indomethacin; however, a combination of both was shown to be more effective, suggesting that juglone may be considered for therapeutic intervention of colon cancer."( Indomethacin and juglone inhibit inflammatory molecules to induce apoptosis in colon cancer cells.
Devaraj, H; Seetha, A; Sudhandiran, G, 2020
)
1.24
"Mice treated with juglone for 2 weeks, as well as Pin1 knockout mice, exhibited increased aortic endothelial NO synthase serine 116 phosphorylation, endothelial dysfunction, and hypertension."( Pin1 deficiency causes endothelial dysfunction and hypertension.
Chatterjee, P; Chiasson, VL; Mitchell, BM; Munshi, N; Young, KJ, 2011
)
0.69

Toxicity

Juglone is more toxic toward bacterial cells under hypoxia than under air. In vitro cytotoxicity studies against melanoma cells indicated that liposomal juglone was more toxic than free jugl one.

ExcerptReferenceRelevance
" Juglone was more toxic toward bacterial cells under hypoxia than under air."( Effects of nitroxide stable radicals on juglone cytotoxicity.
Hirsch, O; Mohsen, M; Samuni, A; Zhang, R, 1994
)
1.47
" High removal rates for biota require broad spectrum biocides that are safe to transport and handle and pose no corrosion problems for ships' structure."( Naphthoquinones as broad spectrum biocides for treatment of ship's ballast water: toxicity to phytoplankton and bacteria.
Cutler, HG; Cutler, SJ; Dawson, R; Graneli, E; Orano-Dawson, CE; Wright, DA, 2007
)
0.34
" Data on natural toxic chemicals could be used for extrapolation methods such as read-across."( The comparative toxicity to soil invertebrates of natural chemicals and their synthetic analogues.
Chaplow, JS; Harman, M; Hopkin, S; Potter, E; Scott, WA; Sims, I; Sorokin, N; Whitaker, J, 2009
)
0.35
" In vitro cytotoxicity studies against melanoma cells indicated that liposomal juglone was more toxic than free juglone."( Evaluation of pharmacokinetic, biodistribution, pharmacodynamic, and toxicity profile of free juglone and its sterically stabilized liposomes.
Aithal, BK; Arumugam, K; Prabhu, V; Rao, BN; Sajankila, SP; Satish Rao, BS; Satyamoorthy, K; Shavi, G; Sunil Kumar, MR; Udupa, N; Upadhya, R, 2011
)
0.82
"Amyloid-β, one of the hallmarks of Alzheimer's disease, is toxic to neurons and causes cell death in the brain."( Cratoxylum formosum Extract Protects against Amyloid-Beta Toxicity in a Caenorhabditis elegans Model of Alzheimer's Disease.
Keowkase, R; Weerapreeyakul, N, 2016
)
0.43
" Our previous research found its toxic effects on oocytes maturation."( Vitamin C protects early mouse embryos against juglone toxicity.
Cheng, W; Liu, H; Tao, R; Xu, H; Zhang, X; Zhou, C, 2020
)
0.82

Pharmacokinetics

Juglone has a short plasma half-life of about 2 h. Liposomal juglone exhibited significantly improved pharmacokinetics with a 12-fold increase in plasmaHalf-life.

ExcerptReferenceRelevance
" Free juglone had short plasma half-life of about 2 h, whereas liposomal juglone exhibited significantly improved pharmacokinetics with a 12-fold increase in plasma half-life."( Evaluation of pharmacokinetic, biodistribution, pharmacodynamic, and toxicity profile of free juglone and its sterically stabilized liposomes.
Aithal, BK; Arumugam, K; Prabhu, V; Rao, BN; Sajankila, SP; Satish Rao, BS; Satyamoorthy, K; Shavi, G; Sunil Kumar, MR; Udupa, N; Upadhya, R, 2011
)
1.07
" To better understand the pharmacokinetic properties of juglone, the protein binding rate of juglone was determined by ultrafiltration method, and the binding affinity and mechanism between JL and human serum albumin (HSA) was investigated in vitro through multi-spectroscopic, thermodynamic, and molecular modeling methods."( Drug-protein binding mechanism of juglone for early pharmacokinetic profiling: Insights from ultrafiltration, multi-spectroscopic and molecular docking methods.
Cai, Q; Cheng, L; Gao, G; Hou, X; Li, S; Lu, N; Zhang, L; Zhao, P, 2017
)
0.98

Compound-Compound Interactions

The purpose of the study was to obtain further in vivo data of antitumor effects and mechanisms triggered by juglone and Q7 in combination with ascorbate.

ExcerptReferenceRelevance
" Naphthoquinones, combined with ascorbate, caused phosphorylation of H2AX and inhibited pAkt."( DNA damage and inhibition of akt pathway in mcf-7 cells and ehrlich tumor in mice treated with 1,4-naphthoquinones in combination with ascorbate.
Benites, J; Calderon, PB; Castro, LS; Correia, JF; Farias, MS; Felipe, KB; Grinevicius, VM; Kviecinski, MR; Ourique, F; Pedrosa, RC; Rios, D; Valderrama, J, 2015
)
0.42
"The purpose of the study was to obtain further in vivo data of antitumor effects and mechanisms triggered by juglone and Q7 in combination with ascorbate."( In vivo inhibition of tumor progression by 5 hydroxy-1,4-naphthoquinone (juglone) and 2-(4-hydroxyanilino)-1,4-naphthoquinone (Q7) in combination with ascorbate.
Benites, J; Calderon, PB; Castro, LSEPW; Gomes Castro, AJ; Kviecinski, MR; Mena Barreto Silva, FR; Ourique, F; Pedrosa, RC; Rios, D; Valderrama, JA; Zirbel, G, 2016
)
0.88
" In this paper, we present the effects of juglone alone and in combination with temozolomide on glioblastoma cells."( Juglone in Combination with Temozolomide Shows a Promising Epigenetic Therapeutic Effect on the Glioblastoma Cell Line.
Barciszewska, AM; Belter, A; Gawrońska, I; Giel-Pietraszuk, M; Naskręt-Barciszewska, MZ, 2023
)
2.62

Bioavailability

ExcerptReferenceRelevance
"A structure-activity relationship to evaluate the effect of bioavailability was performed."( Influence of lipophilicity in O-acyl and O-alkyl derivatives of juglone and lawsone: a structure-activity relationship study in the search for natural herbicide models.
Chinchilla, N; Durán, AG; Macías, FA; Molinillo, JM, 2018
)
0.72
" Many forms of PyC have sorptive properties that can reduce the bioavailability of allelochemicals."( Biochar mitigates allelopathic effects in temperate trees.
Sujeeun, L; Thomas, SC, 2023
)
0.91
"This study aimed to improve the thermodynamic performance of nanoliposomes (NLs) using fucoidan (F) as the second-layer coating biopolymer along with chitosan (CS), to control the delivery and bioavailability of catechin (C) and juglone (J)."( Synthesis and characterization of fucoidan/chitosan-coated nanoliposomes for enhanced stability and oral bioavailability of hydrophilic catechin and hydrophobic juglone.
Ettoumi, FE; Huang, H; Li, L; Luo, Z; Xu, Y; Zhang, R, 2023
)
1.29

Dosage Studied

The chitin synthetase inhibitor plumbagin and its 2-demethyl derivative juglone were found to inhibit in a dose-response fashion the cytochrome P-450 dependent ecdysone 20-monooxygenase activity associated with adult female Aedes aegypti, wandering stage larvae of Drosophila melanogaster.

ExcerptRelevanceReference
"The chitin synthetase inhibitor plumbagin and its 2-demethyl derivative juglone were found to inhibit in a dose-response fashion the cytochrome P-450 dependent ecdysone 20-monooxygenase activity associated with adult female Aedes aegypti, wandering stage larvae of Drosophila melanogaster, and fat body and midgut from last instar larvae of Manduca sexta."( Effects of the chitin synthetase inhibitor plumbagin and its 2-demethyl derivative juglone on insect ecdysone 20-monooxygenase activity.
Mitchell, MJ; Smith, SL, 1988
)
0.73
" Groups of female Sprague-Dawley rats were dosed by oral intubation on 5 consecutive days with either juglone or plumbagin at 12."( Induction of quinone reductase and glutathione transferase in rat tissues by juglone and plumbagin.
Munday, CM; Munday, R, 2000
)
0.75
" In dose-response studies, induced thermotolerance paralleled the induced increase in life expectancy, which is consistent with a common origin."( Multiple stressors in Caenorhabditis elegans induce stress hormesis and extended longevity.
Cypser, JR; Johnson, TE, 2002
)
0.31
" High concentrations of juglone-derived radioactivity were found in kidney for all three dosing routes."( Metabolism and disposition of juglone in male F344 rats.
Burka, LT; Chen, LJ; Lebetkin, EH,
)
0.73
" Downregulation of Pin1 gene dosage attenuated premature cranial suture closure and other phenotypes of AS in Fgfr2S252W/+ mutant mice."( PIN1 is a new therapeutic target of craniosynostosis.
Bae, HS; Baek, JH; Cho, YD; Choi, KY; Kim, BS; Kim, WJ; Lee, YS; Ryoo, HM; Shin, HR; Woo, KM; Yoon, HI, 2018
)
0.48
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (3)

RoleDescription
herbicideA substance used to destroy plant pests.
reactive oxygen species generatorAny entity used to generate reactive oxygen species.
geroprotectorAny compound that supports healthy aging, slows the biological aging process, or extends lifespan.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
hydroxy-1,4-naphthoquinoneAny member of the class of 1,4-naphthoquinones in which the naphthoquinone moiety is substituted by at least one hydroxy group.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (8)

PathwayProteinsCompounds
isoflavonoid biosynthesis II124
(-)-maackiain biosynthesis016
juglone biosynthesis07
superpathway of pterocarpan biosynthesis (via formononetin)031
superpathway of formononetin derivative biosynthesis031
superpathway of isoflavonoids (via naringenin)028
(-)-maackiain biosynthesis217
isoflavonoid biosynthesis II128
juglone degradation011
superpathway of pterocarpan biosynthesis (via formononetin)334
superpathway of isoflavonoids (via naringenin)034
superpathway of formononetin derivative biosynthesis234
colchicine biosynthesis021

Protein Targets (69)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASEHomo sapiens (human)Potency4.10380.003245.467312,589.2998AID2517; AID2572
Chain A, TYROSYL-DNA PHOSPHODIESTERASEHomo sapiens (human)Potency0.35480.004023.8416100.0000AID485290
Chain A, Breast cancer type 1 susceptibility proteinHomo sapiens (human)Potency3.16231.258920.440939.8107AID892
Chain A, Putative fructose-1,6-bisphosphate aldolaseGiardia intestinalisPotency4.57490.140911.194039.8107AID2451
Chain A, HADH2 proteinHomo sapiens (human)Potency0.79430.025120.237639.8107AID893
Chain B, HADH2 proteinHomo sapiens (human)Potency0.79430.025120.237639.8107AID893
Chain A, 2-oxoglutarate OxygenaseHomo sapiens (human)Potency7.07950.177814.390939.8107AID2147
Chain A, ATP-DEPENDENT DNA HELICASE Q1Homo sapiens (human)Potency4.72950.125919.1169125.8920AID2549; AID2708
Chain A, CruzipainTrypanosoma cruziPotency7.94330.002014.677939.8107AID1476
15-lipoxygenase, partialHomo sapiens (human)Potency1.99530.012610.691788.5700AID887
USP1 protein, partialHomo sapiens (human)Potency8.91250.031637.5844354.8130AID504865
TDP1 proteinHomo sapiens (human)Potency24.51920.000811.382244.6684AID686978; AID686979
Microtubule-associated protein tauHomo sapiens (human)Potency12.67280.180013.557439.8107AID1460; AID1468
aldehyde dehydrogenase 1 family, member A1Homo sapiens (human)Potency12.58930.011212.4002100.0000AID1030
Bloom syndrome protein isoform 1Homo sapiens (human)Potency4.39290.540617.639296.1227AID2528
cellular tumor antigen p53 isoform aHomo sapiens (human)Potency10.00000.316212.443531.6228AID902; AID924
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1Homo sapiens (human)Potency14.12540.001815.663839.8107AID894
runt-related transcription factor 1 isoform AML1bHomo sapiens (human)Potency17.32430.02007.985839.8107AID504370; AID504374; AID504375
vitamin D3 receptor isoform VDRAHomo sapiens (human)Potency35.71680.354828.065989.1251AID504847
thyroid hormone receptor beta isoform aHomo sapiens (human)Potency27.21050.010039.53711,122.0200AID1469; AID1479
core-binding factor subunit beta isoform 2Homo sapiens (human)Potency17.32430.02007.985839.8107AID504370; AID504374; AID504375
mitogen-activated protein kinase 1Homo sapiens (human)Potency6.30960.039816.784239.8107AID995
ubiquitin carboxyl-terminal hydrolase 2 isoform aHomo sapiens (human)Potency12.58930.65619.452025.1189AID927
nuclear receptor ROR-gamma isoform 1Mus musculus (house mouse)Potency11.22020.00798.23321,122.0200AID2551
DNA polymerase kappa isoform 1Homo sapiens (human)Potency2.91510.031622.3146100.0000AID588579
cytochrome P450 3A4 isoform 1Homo sapiens (human)Potency39.81070.031610.279239.8107AID884; AID885
histone acetyltransferase KAT2A isoform 1Homo sapiens (human)Potency1.43480.251215.843239.8107AID504327
caspase-1 isoform alpha precursorHomo sapiens (human)Potency19.95260.000311.448431.6228AID900
Gamma-aminobutyric acid receptor subunit piRattus norvegicus (Norway rat)Potency39.81071.000012.224831.6228AID885
Polyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)Potency3.16230.316212.765731.6228AID881
Integrin beta-3Homo sapiens (human)Potency10.00000.316211.415731.6228AID924
Integrin alpha-IIbHomo sapiens (human)Potency10.00000.316211.415731.6228AID924
Gamma-aminobutyric acid receptor subunit beta-1Rattus norvegicus (Norway rat)Potency39.81071.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit deltaRattus norvegicus (Norway rat)Potency39.81071.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-2Rattus norvegicus (Norway rat)Potency39.81071.000012.224831.6228AID885
Glutamate receptor 1Rattus norvegicus (Norway rat)Potency10.00000.01418.602439.8107AID2572
Glutamate receptor 2Rattus norvegicus (Norway rat)Potency10.00000.001551.739315,848.9004AID2572
Glutamate receptor 3Rattus norvegicus (Norway rat)Potency10.00000.01418.602439.8107AID2572
Glutamate receptor 4Rattus norvegicus (Norway rat)Potency10.00000.01418.602439.8107AID2572
Gamma-aminobutyric acid receptor subunit alpha-5Rattus norvegicus (Norway rat)Potency39.81071.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-3Rattus norvegicus (Norway rat)Potency39.81071.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-1Rattus norvegicus (Norway rat)Potency39.81071.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-2Rattus norvegicus (Norway rat)Potency39.81071.000012.224831.6228AID885
Platelet-activating factor receptorHomo sapiens (human)Potency3.162310.000025.781039.8107AID892
Gamma-aminobutyric acid receptor subunit alpha-4Rattus norvegicus (Norway rat)Potency39.81071.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-3Rattus norvegicus (Norway rat)Potency39.81071.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-6Rattus norvegicus (Norway rat)Potency39.81071.000012.224831.6228AID885
Histamine H2 receptorCavia porcellus (domestic guinea pig)Potency3.16230.00638.235039.8107AID881
Caspase-7Homo sapiens (human)Potency1.00003.981118.585631.6228AID889
Gamma-aminobutyric acid receptor subunit alpha-1Rattus norvegicus (Norway rat)Potency39.81071.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit beta-3Rattus norvegicus (Norway rat)Potency39.81071.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit beta-2Rattus norvegicus (Norway rat)Potency39.81071.000012.224831.6228AID885
Disintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)Potency12.58931.584913.004325.1189AID927
GABA theta subunitRattus norvegicus (Norway rat)Potency39.81071.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit epsilonRattus norvegicus (Norway rat)Potency39.81071.000012.224831.6228AID885
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, (3R)-hydroxymyristoyl-acyl carrier protein dehydrataseHelicobacter pyloriKi6.80006.80006.80006.8000AID977610
Chain B, (3R)-hydroxymyristoyl-acyl carrier protein dehydrataseHelicobacter pyloriKi6.80006.80006.80006.8000AID977610
3-hydroxyacyl-[acyl-carrier-protein] dehydratase FabZYersinia pseudotuberculosis YPIIIIC50 (µMol)5.35005.30006.12507.7000AID1801643
Aurora kinase AHomo sapiens (human)IC50 (µMol)0.05000.00000.46208.6000AID1869314
DNA topoisomerase 1Homo sapiens (human)IC50 (µMol)8.26000.02101.862610.0000AID1758988
Indoleamine 2,3-dioxygenase 1Homo sapiens (human)IC50 (µMol)1.00000.05373.075710.0000AID1798473; AID326467
Amine oxidase [flavin-containing] AHomo sapiens (human)IC50 (µMol)3.03500.00002.37899.7700AID1801570
Dual specificity protein phosphatase 1Mus musculus (house mouse)IC50 (µMol)13.00008.45008.91009.3700AID417087
M-phase inducer phosphatase 2Homo sapiens (human)IC50 (µMol)1.98000.10002.31039.5100AID417086
Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)IC50 (µMol)9.53400.82003.90675.9000AID1175274; AID1391263; AID1420355; AID1464038; AID1594071
Dual specificity protein phosphatase 6Rattus norvegicus (Norway rat)IC50 (µMol)12.40006.90006.90006.9000AID417088
Aurora kinase BHomo sapiens (human)IC50 (µMol)0.62000.00030.96349.8000AID1869315
5-lipoxygenase Bos taurus (cattle)IC50 (µMol)17.00000.18001.75824.0000AID160507
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Transient receptor potential cation channel subfamily A member 1Homo sapiens (human)EC50 (µMol)1.70000.00033.166210.0000AID1625339
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
DNA topoisomerase 1Homo sapiens (human)MIC5.00000.01002.00175.0000AID228426
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (293)

Processvia Protein(s)Taxonomy
protein phosphorylationAurora kinase AHomo sapiens (human)
response to woundingAurora kinase AHomo sapiens (human)
liver regenerationAurora kinase AHomo sapiens (human)
G2/M transition of mitotic cell cycleAurora kinase AHomo sapiens (human)
mitotic cell cycleAurora kinase AHomo sapiens (human)
chromatin remodelingAurora kinase AHomo sapiens (human)
protein phosphorylationAurora kinase AHomo sapiens (human)
apoptotic processAurora kinase AHomo sapiens (human)
spindle organizationAurora kinase AHomo sapiens (human)
spindle assembly involved in female meiosis IAurora kinase AHomo sapiens (human)
mitotic centrosome separationAurora kinase AHomo sapiens (human)
anterior/posterior axis specificationAurora kinase AHomo sapiens (human)
regulation of G2/M transition of mitotic cell cycleAurora kinase AHomo sapiens (human)
negative regulation of gene expressionAurora kinase AHomo sapiens (human)
peptidyl-serine phosphorylationAurora kinase AHomo sapiens (human)
regulation of protein stabilityAurora kinase AHomo sapiens (human)
negative regulation of protein bindingAurora kinase AHomo sapiens (human)
positive regulation of proteasomal ubiquitin-dependent protein catabolic processAurora kinase AHomo sapiens (human)
negative regulation of apoptotic processAurora kinase AHomo sapiens (human)
proteasome-mediated ubiquitin-dependent protein catabolic processAurora kinase AHomo sapiens (human)
positive regulation of mitotic nuclear divisionAurora kinase AHomo sapiens (human)
positive regulation of mitotic cell cycleAurora kinase AHomo sapiens (human)
regulation of centrosome cycleAurora kinase AHomo sapiens (human)
protein autophosphorylationAurora kinase AHomo sapiens (human)
cell divisionAurora kinase AHomo sapiens (human)
centrosome localizationAurora kinase AHomo sapiens (human)
cilium disassemblyAurora kinase AHomo sapiens (human)
protein localization to centrosomeAurora kinase AHomo sapiens (human)
positive regulation of mitochondrial fissionAurora kinase AHomo sapiens (human)
positive regulation of oocyte maturationAurora kinase AHomo sapiens (human)
regulation of signal transduction by p53 class mediatorAurora kinase AHomo sapiens (human)
neuron projection extensionAurora kinase AHomo sapiens (human)
mitotic spindle organizationAurora kinase AHomo sapiens (human)
regulation of cytokinesisAurora kinase AHomo sapiens (human)
lipid metabolic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
phospholipid metabolic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
apoptotic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
negative regulation of cell population proliferationPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
positive regulation of macrophage derived foam cell differentiationPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
arachidonic acid metabolic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
negative regulation of cell migrationPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
prostate gland developmentPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
regulation of epithelial cell differentiationPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
positive regulation of chemokine productionPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
positive regulation of peroxisome proliferator activated receptor signaling pathwayPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
positive regulation of keratinocyte differentiationPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
negative regulation of cell cyclePolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
negative regulation of growthPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
hepoxilin biosynthetic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
endocannabinoid signaling pathwayPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
cannabinoid biosynthetic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
lipoxin A4 biosynthetic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
linoleic acid metabolic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
lipid oxidationPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
lipoxygenase pathwayPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
monoatomic ion transportTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
intracellular calcium ion homeostasisTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
cell surface receptor signaling pathwayTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
response to coldTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
response to xenobiotic stimulusTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
response to organic substanceTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
response to organic cyclic compoundTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
sensory perception of painTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
calcium-mediated signalingTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
response to painTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
thermoceptionTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
detection of mechanical stimulus involved in sensory perception of painTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
detection of chemical stimulus involved in sensory perception of painTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
protein homotetramerizationTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
cellular response to hydrogen peroxideTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
calcium ion transmembrane transportTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
cellular response to organic substanceTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
negative regulation of low-density lipoprotein receptor activityIntegrin beta-3Homo sapiens (human)
positive regulation of protein phosphorylationIntegrin beta-3Homo sapiens (human)
positive regulation of endothelial cell proliferationIntegrin beta-3Homo sapiens (human)
positive regulation of cell-matrix adhesionIntegrin beta-3Homo sapiens (human)
cell-substrate junction assemblyIntegrin beta-3Homo sapiens (human)
cell adhesionIntegrin beta-3Homo sapiens (human)
cell-matrix adhesionIntegrin beta-3Homo sapiens (human)
integrin-mediated signaling pathwayIntegrin beta-3Homo sapiens (human)
embryo implantationIntegrin beta-3Homo sapiens (human)
blood coagulationIntegrin beta-3Homo sapiens (human)
positive regulation of endothelial cell migrationIntegrin beta-3Homo sapiens (human)
positive regulation of gene expressionIntegrin beta-3Homo sapiens (human)
negative regulation of macrophage derived foam cell differentiationIntegrin beta-3Homo sapiens (human)
positive regulation of fibroblast migrationIntegrin beta-3Homo sapiens (human)
negative regulation of lipid storageIntegrin beta-3Homo sapiens (human)
response to activityIntegrin beta-3Homo sapiens (human)
smooth muscle cell migrationIntegrin beta-3Homo sapiens (human)
positive regulation of smooth muscle cell migrationIntegrin beta-3Homo sapiens (human)
platelet activationIntegrin beta-3Homo sapiens (human)
positive regulation of vascular endothelial growth factor receptor signaling pathwayIntegrin beta-3Homo sapiens (human)
cell-substrate adhesionIntegrin beta-3Homo sapiens (human)
activation of protein kinase activityIntegrin beta-3Homo sapiens (human)
negative regulation of lipid transportIntegrin beta-3Homo sapiens (human)
regulation of protein localizationIntegrin beta-3Homo sapiens (human)
regulation of actin cytoskeleton organizationIntegrin beta-3Homo sapiens (human)
cell adhesion mediated by integrinIntegrin beta-3Homo sapiens (human)
positive regulation of cell adhesion mediated by integrinIntegrin beta-3Homo sapiens (human)
positive regulation of osteoblast proliferationIntegrin beta-3Homo sapiens (human)
heterotypic cell-cell adhesionIntegrin beta-3Homo sapiens (human)
substrate adhesion-dependent cell spreadingIntegrin beta-3Homo sapiens (human)
tube developmentIntegrin beta-3Homo sapiens (human)
wound healing, spreading of epidermal cellsIntegrin beta-3Homo sapiens (human)
cellular response to platelet-derived growth factor stimulusIntegrin beta-3Homo sapiens (human)
apolipoprotein A-I-mediated signaling pathwayIntegrin beta-3Homo sapiens (human)
wound healingIntegrin beta-3Homo sapiens (human)
apoptotic cell clearanceIntegrin beta-3Homo sapiens (human)
regulation of bone resorptionIntegrin beta-3Homo sapiens (human)
positive regulation of angiogenesisIntegrin beta-3Homo sapiens (human)
positive regulation of bone resorptionIntegrin beta-3Homo sapiens (human)
symbiont entry into host cellIntegrin beta-3Homo sapiens (human)
platelet-derived growth factor receptor signaling pathwayIntegrin beta-3Homo sapiens (human)
positive regulation of fibroblast proliferationIntegrin beta-3Homo sapiens (human)
mesodermal cell differentiationIntegrin beta-3Homo sapiens (human)
positive regulation of smooth muscle cell proliferationIntegrin beta-3Homo sapiens (human)
positive regulation of peptidyl-tyrosine phosphorylationIntegrin beta-3Homo sapiens (human)
negative regulation of lipoprotein metabolic processIntegrin beta-3Homo sapiens (human)
negative chemotaxisIntegrin beta-3Homo sapiens (human)
regulation of release of sequestered calcium ion into cytosolIntegrin beta-3Homo sapiens (human)
regulation of serotonin uptakeIntegrin beta-3Homo sapiens (human)
angiogenesis involved in wound healingIntegrin beta-3Homo sapiens (human)
positive regulation of ERK1 and ERK2 cascadeIntegrin beta-3Homo sapiens (human)
platelet aggregationIntegrin beta-3Homo sapiens (human)
cellular response to mechanical stimulusIntegrin beta-3Homo sapiens (human)
cellular response to xenobiotic stimulusIntegrin beta-3Homo sapiens (human)
positive regulation of glomerular mesangial cell proliferationIntegrin beta-3Homo sapiens (human)
blood coagulation, fibrin clot formationIntegrin beta-3Homo sapiens (human)
maintenance of postsynaptic specialization structureIntegrin beta-3Homo sapiens (human)
regulation of postsynaptic neurotransmitter receptor internalizationIntegrin beta-3Homo sapiens (human)
regulation of postsynaptic neurotransmitter receptor diffusion trappingIntegrin beta-3Homo sapiens (human)
positive regulation of substrate adhesion-dependent cell spreadingIntegrin beta-3Homo sapiens (human)
positive regulation of adenylate cyclase-inhibiting opioid receptor signaling pathwayIntegrin beta-3Homo sapiens (human)
regulation of trophoblast cell migrationIntegrin beta-3Homo sapiens (human)
regulation of extracellular matrix organizationIntegrin beta-3Homo sapiens (human)
cellular response to insulin-like growth factor stimulusIntegrin beta-3Homo sapiens (human)
negative regulation of endothelial cell apoptotic processIntegrin beta-3Homo sapiens (human)
positive regulation of T cell migrationIntegrin beta-3Homo sapiens (human)
cell migrationIntegrin beta-3Homo sapiens (human)
positive regulation of leukocyte migrationIntegrin alpha-IIbHomo sapiens (human)
cell-matrix adhesionIntegrin alpha-IIbHomo sapiens (human)
integrin-mediated signaling pathwayIntegrin alpha-IIbHomo sapiens (human)
angiogenesisIntegrin alpha-IIbHomo sapiens (human)
cell-cell adhesionIntegrin alpha-IIbHomo sapiens (human)
cell adhesion mediated by integrinIntegrin alpha-IIbHomo sapiens (human)
DNA topological changeDNA topoisomerase 1Homo sapiens (human)
chromatin remodelingDNA topoisomerase 1Homo sapiens (human)
circadian rhythmDNA topoisomerase 1Homo sapiens (human)
response to xenobiotic stimulusDNA topoisomerase 1Homo sapiens (human)
programmed cell deathDNA topoisomerase 1Homo sapiens (human)
phosphorylationDNA topoisomerase 1Homo sapiens (human)
peptidyl-serine phosphorylationDNA topoisomerase 1Homo sapiens (human)
circadian regulation of gene expressionDNA topoisomerase 1Homo sapiens (human)
embryonic cleavageDNA topoisomerase 1Homo sapiens (human)
chromosome segregationDNA topoisomerase 1Homo sapiens (human)
DNA replicationDNA topoisomerase 1Homo sapiens (human)
regulation of activated T cell proliferationIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
positive regulation of T cell tolerance inductionIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
positive regulation of chronic inflammatory responseIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
positive regulation of type 2 immune responseIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
tryptophan catabolic processIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
inflammatory responseIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
female pregnancyIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
tryptophan catabolic process to kynurenineIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
response to lipopolysaccharideIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
negative regulation of interleukin-10 productionIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
positive regulation of interleukin-12 productionIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
multicellular organismal response to stressIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
kynurenic acid biosynthetic processIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
swimming behaviorIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
T cell proliferationIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
negative regulation of T cell proliferationIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
negative regulation of T cell apoptotic processIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
positive regulation of T cell apoptotic processIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
'de novo' NAD biosynthetic process from tryptophanIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
biogenic amine metabolic processAmine oxidase [flavin-containing] AHomo sapiens (human)
positive regulation of signal transductionAmine oxidase [flavin-containing] AHomo sapiens (human)
dopamine catabolic processAmine oxidase [flavin-containing] AHomo sapiens (human)
positive regulation of cellular extravasationPlatelet-activating factor receptorHomo sapiens (human)
regulation of transcription by RNA polymerase IIPlatelet-activating factor receptorHomo sapiens (human)
chemotaxisPlatelet-activating factor receptorHomo sapiens (human)
inflammatory responsePlatelet-activating factor receptorHomo sapiens (human)
immune responsePlatelet-activating factor receptorHomo sapiens (human)
phospholipase C-activating G protein-coupled receptor signaling pathwayPlatelet-activating factor receptorHomo sapiens (human)
parturitionPlatelet-activating factor receptorHomo sapiens (human)
response to symbiotic bacteriumPlatelet-activating factor receptorHomo sapiens (human)
lipopolysaccharide-mediated signaling pathwayPlatelet-activating factor receptorHomo sapiens (human)
positive regulation of interleukin-6 productionPlatelet-activating factor receptorHomo sapiens (human)
positive regulation of tumor necrosis factor productionPlatelet-activating factor receptorHomo sapiens (human)
inositol trisphosphate biosynthetic processPlatelet-activating factor receptorHomo sapiens (human)
G protein-coupled purinergic nucleotide receptor signaling pathwayPlatelet-activating factor receptorHomo sapiens (human)
positive regulation of neutrophil degranulationPlatelet-activating factor receptorHomo sapiens (human)
transcytosisPlatelet-activating factor receptorHomo sapiens (human)
positive regulation of translationPlatelet-activating factor receptorHomo sapiens (human)
negative regulation of blood pressurePlatelet-activating factor receptorHomo sapiens (human)
positive regulation of smooth muscle cell proliferationPlatelet-activating factor receptorHomo sapiens (human)
positive regulation of inositol phosphate biosynthetic processPlatelet-activating factor receptorHomo sapiens (human)
cellular response to gravityPlatelet-activating factor receptorHomo sapiens (human)
cellular response to cAMPPlatelet-activating factor receptorHomo sapiens (human)
cellular response to fatty acidPlatelet-activating factor receptorHomo sapiens (human)
response to dexamethasonePlatelet-activating factor receptorHomo sapiens (human)
positive regulation of leukocyte tethering or rollingPlatelet-activating factor receptorHomo sapiens (human)
positive regulation of transcytosisPlatelet-activating factor receptorHomo sapiens (human)
positive regulation of maternal process involved in parturitionPlatelet-activating factor receptorHomo sapiens (human)
positive regulation of gastro-intestinal system smooth muscle contractionPlatelet-activating factor receptorHomo sapiens (human)
cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholinePlatelet-activating factor receptorHomo sapiens (human)
G protein-coupled receptor signaling pathwayPlatelet-activating factor receptorHomo sapiens (human)
G2/M transition of mitotic cell cycleM-phase inducer phosphatase 2Homo sapiens (human)
mitotic cell cycleM-phase inducer phosphatase 2Homo sapiens (human)
oocyte maturationM-phase inducer phosphatase 2Homo sapiens (human)
protein phosphorylationM-phase inducer phosphatase 2Homo sapiens (human)
female meiosis IM-phase inducer phosphatase 2Homo sapiens (human)
positive regulation of cell population proliferationM-phase inducer phosphatase 2Homo sapiens (human)
positive regulation of G2/M transition of mitotic cell cycleM-phase inducer phosphatase 2Homo sapiens (human)
positive regulation of cytokinesisM-phase inducer phosphatase 2Homo sapiens (human)
positive regulation of mitotic cell cycleM-phase inducer phosphatase 2Homo sapiens (human)
cell divisionM-phase inducer phosphatase 2Homo sapiens (human)
positive regulation of G2/MI transition of meiotic cell cycleM-phase inducer phosphatase 2Homo sapiens (human)
proteolysisCaspase-7Homo sapiens (human)
apoptotic processCaspase-7Homo sapiens (human)
heart developmentCaspase-7Homo sapiens (human)
response to UVCaspase-7Homo sapiens (human)
protein processingCaspase-7Homo sapiens (human)
protein catabolic processCaspase-7Homo sapiens (human)
defense response to bacteriumCaspase-7Homo sapiens (human)
fibroblast apoptotic processCaspase-7Homo sapiens (human)
striated muscle cell differentiationCaspase-7Homo sapiens (human)
neuron apoptotic processCaspase-7Homo sapiens (human)
protein maturationCaspase-7Homo sapiens (human)
lymphocyte apoptotic processCaspase-7Homo sapiens (human)
cellular response to lipopolysaccharideCaspase-7Homo sapiens (human)
cellular response to staurosporineCaspase-7Homo sapiens (human)
execution phase of apoptosisCaspase-7Homo sapiens (human)
positive regulation of plasma membrane repairCaspase-7Homo sapiens (human)
positive regulation of neuron apoptotic processCaspase-7Homo sapiens (human)
positive regulation of epidermal growth factor receptor signaling pathwayDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
response to hypoxiaDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
neutrophil mediated immunityDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
germinal center formationDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
positive regulation of leukocyte chemotaxisDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
proteolysisDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
membrane protein ectodomain proteolysisDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
cell adhesionDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
Notch receptor processingDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
positive regulation of cell population proliferationDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
response to xenobiotic stimulusDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
positive regulation of T cell chemotaxisDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
protein processingDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
signal releaseDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
B cell differentiationDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
positive regulation of cell growthDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
positive regulation of cell migrationDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
negative regulation of transforming growth factor beta receptor signaling pathwayDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
response to lipopolysaccharideDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
positive regulation of chemokine productionDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
positive regulation of tumor necrosis factor productionDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
regulation of mast cell apoptotic processDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
T cell differentiation in thymusDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
cell adhesion mediated by integrinDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
wound healing, spreading of epidermal cellsDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
amyloid precursor protein catabolic processDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
positive regulation of blood vessel endothelial cell migrationDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
positive regulation of cyclin-dependent protein serine/threonine kinase activityDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
positive regulation of epidermal growth factor-activated receptor activityDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
positive regulation of epidermal growth factor receptor signaling pathwayDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
spleen developmentDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
cell motilityDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
defense response to Gram-positive bacteriumDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
cellular response to high density lipoprotein particle stimulusDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
commissural neuron axon guidanceDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
negative regulation of cold-induced thermogenesisDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
positive regulation of G1/S transition of mitotic cell cycleDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
positive regulation of tumor necrosis factor-mediated signaling pathwayDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
positive regulation of vascular endothelial cell proliferationDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
Notch signaling pathwayDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
microtubule polymerizationPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
positive regulation of protein phosphorylationPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
regulation of cytokinesisPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
protein peptidyl-prolyl isomerizationPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
response to hypoxiaPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
regulation of protein phosphorylationPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
regulation of mitotic nuclear divisionPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
regulation of gene expressionPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
neuron differentiationPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
negative regulation of transforming growth factor beta receptor signaling pathwayPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
regulation of protein stabilityPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
negative regulation of protein bindingPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
positive regulation of protein bindingPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
positive regulation of protein dephosphorylationPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
negative regulation of protein catabolic processPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
positive regulation of GTPase activityPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
positive regulation of transcription by RNA polymerase IIPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
synapse organizationPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
protein stabilizationPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
negative regulation of SMAD protein signal transductionPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
negative regulation of ERK1 and ERK2 cascadePeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
positive regulation of canonical Wnt signaling pathwayPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
regulation of protein localization to nucleusPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
negative regulation of amyloid-beta formationPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
negative regulation of cell motilityPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
negative regulation of transcription by RNA polymerase IIAurora kinase BHomo sapiens (human)
mitotic cell cycleAurora kinase BHomo sapiens (human)
mitotic cytokinesisAurora kinase BHomo sapiens (human)
negative regulation of B cell apoptotic processAurora kinase BHomo sapiens (human)
protein phosphorylationAurora kinase BHomo sapiens (human)
spindle organizationAurora kinase BHomo sapiens (human)
attachment of spindle microtubules to kinetochoreAurora kinase BHomo sapiens (human)
abscissionAurora kinase BHomo sapiens (human)
negative regulation of protein bindingAurora kinase BHomo sapiens (human)
positive regulation of telomere maintenance via telomeraseAurora kinase BHomo sapiens (human)
negative regulation of cytokinesisAurora kinase BHomo sapiens (human)
positive regulation of cytokinesisAurora kinase BHomo sapiens (human)
protein localization to kinetochoreAurora kinase BHomo sapiens (human)
cellular response to UVAurora kinase BHomo sapiens (human)
cleavage furrow formationAurora kinase BHomo sapiens (human)
post-translational protein modificationAurora kinase BHomo sapiens (human)
cell cycle G2/M phase transitionAurora kinase BHomo sapiens (human)
mitotic cytokinesis checkpoint signalingAurora kinase BHomo sapiens (human)
negative regulation of innate immune responseAurora kinase BHomo sapiens (human)
protein autophosphorylationAurora kinase BHomo sapiens (human)
mitotic spindle midzone assemblyAurora kinase BHomo sapiens (human)
positive regulation of telomerase activityAurora kinase BHomo sapiens (human)
regulation of chromosome segregationAurora kinase BHomo sapiens (human)
positive regulation of mitotic sister chromatid segregationAurora kinase BHomo sapiens (human)
positive regulation of mitotic cell cycle spindle assembly checkpointAurora kinase BHomo sapiens (human)
mitotic spindle assemblyAurora kinase BHomo sapiens (human)
negative regulation of cGAS/STING signaling pathwayAurora kinase BHomo sapiens (human)
regulation of signal transduction by p53 class mediatorAurora kinase BHomo sapiens (human)
positive regulation of mitotic sister chromatid separationAurora kinase BHomo sapiens (human)
positive regulation of attachment of mitotic spindle microtubules to kinetochoreAurora kinase BHomo sapiens (human)
positive regulation of mitotic cytokinesisAurora kinase BHomo sapiens (human)
positive regulation of telomere cappingAurora kinase BHomo sapiens (human)
positive regulation of lateral attachment of mitotic spindle microtubules to kinetochoreAurora kinase BHomo sapiens (human)
mitotic spindle organizationAurora kinase BHomo sapiens (human)
regulation of cytokinesisAurora kinase BHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (97)

Processvia Protein(s)Taxonomy
protein kinase activityAurora kinase AHomo sapiens (human)
protein serine/threonine kinase activityAurora kinase AHomo sapiens (human)
protein serine/threonine/tyrosine kinase activityAurora kinase AHomo sapiens (human)
protein bindingAurora kinase AHomo sapiens (human)
ATP bindingAurora kinase AHomo sapiens (human)
protein kinase bindingAurora kinase AHomo sapiens (human)
ubiquitin protein ligase bindingAurora kinase AHomo sapiens (human)
histone H3S10 kinase activityAurora kinase AHomo sapiens (human)
protein heterodimerization activityAurora kinase AHomo sapiens (human)
protein serine kinase activityAurora kinase AHomo sapiens (human)
molecular function activator activityAurora kinase AHomo sapiens (human)
iron ion bindingPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
calcium ion bindingPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
protein bindingPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
lipid bindingPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
linoleate 13S-lipoxygenase activityPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
arachidonate 8(S)-lipoxygenase activityPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
arachidonate 15-lipoxygenase activityPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
linoleate 9S-lipoxygenase activityPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
calcium channel activityTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
channel activityTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
intracellularly gated calcium channel activityTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
identical protein bindingTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
temperature-gated cation channel activityTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
fibroblast growth factor bindingIntegrin beta-3Homo sapiens (human)
C-X3-C chemokine bindingIntegrin beta-3Homo sapiens (human)
insulin-like growth factor I bindingIntegrin beta-3Homo sapiens (human)
neuregulin bindingIntegrin beta-3Homo sapiens (human)
virus receptor activityIntegrin beta-3Homo sapiens (human)
fibronectin bindingIntegrin beta-3Homo sapiens (human)
protease bindingIntegrin beta-3Homo sapiens (human)
protein disulfide isomerase activityIntegrin beta-3Homo sapiens (human)
protein kinase C bindingIntegrin beta-3Homo sapiens (human)
platelet-derived growth factor receptor bindingIntegrin beta-3Homo sapiens (human)
integrin bindingIntegrin beta-3Homo sapiens (human)
protein bindingIntegrin beta-3Homo sapiens (human)
coreceptor activityIntegrin beta-3Homo sapiens (human)
enzyme bindingIntegrin beta-3Homo sapiens (human)
identical protein bindingIntegrin beta-3Homo sapiens (human)
vascular endothelial growth factor receptor 2 bindingIntegrin beta-3Homo sapiens (human)
metal ion bindingIntegrin beta-3Homo sapiens (human)
cell adhesion molecule bindingIntegrin beta-3Homo sapiens (human)
extracellular matrix bindingIntegrin beta-3Homo sapiens (human)
fibrinogen bindingIntegrin beta-3Homo sapiens (human)
protein bindingIntegrin alpha-IIbHomo sapiens (human)
identical protein bindingIntegrin alpha-IIbHomo sapiens (human)
metal ion bindingIntegrin alpha-IIbHomo sapiens (human)
extracellular matrix bindingIntegrin alpha-IIbHomo sapiens (human)
molecular adaptor activityIntegrin alpha-IIbHomo sapiens (human)
fibrinogen bindingIntegrin alpha-IIbHomo sapiens (human)
integrin bindingIntegrin alpha-IIbHomo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingDNA topoisomerase 1Homo sapiens (human)
DNA bindingDNA topoisomerase 1Homo sapiens (human)
chromatin bindingDNA topoisomerase 1Homo sapiens (human)
double-stranded DNA bindingDNA topoisomerase 1Homo sapiens (human)
single-stranded DNA bindingDNA topoisomerase 1Homo sapiens (human)
RNA bindingDNA topoisomerase 1Homo sapiens (human)
DNA topoisomerase type I (single strand cut, ATP-independent) activityDNA topoisomerase 1Homo sapiens (human)
protein serine/threonine kinase activityDNA topoisomerase 1Homo sapiens (human)
protein bindingDNA topoisomerase 1Homo sapiens (human)
ATP bindingDNA topoisomerase 1Homo sapiens (human)
DNA binding, bendingDNA topoisomerase 1Homo sapiens (human)
protein domain specific bindingDNA topoisomerase 1Homo sapiens (human)
supercoiled DNA bindingDNA topoisomerase 1Homo sapiens (human)
electron transfer activityIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
heme bindingIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
indoleamine 2,3-dioxygenase activityIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
metal ion bindingIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
tryptophan 2,3-dioxygenase activityIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
protein bindingAmine oxidase [flavin-containing] AHomo sapiens (human)
primary amine oxidase activityAmine oxidase [flavin-containing] AHomo sapiens (human)
aliphatic amine oxidase activityAmine oxidase [flavin-containing] AHomo sapiens (human)
monoamine oxidase activityAmine oxidase [flavin-containing] AHomo sapiens (human)
flavin adenine dinucleotide bindingAmine oxidase [flavin-containing] AHomo sapiens (human)
lipopolysaccharide bindingPlatelet-activating factor receptorHomo sapiens (human)
lipopolysaccharide immune receptor activityPlatelet-activating factor receptorHomo sapiens (human)
G protein-coupled receptor activityPlatelet-activating factor receptorHomo sapiens (human)
platelet activating factor receptor activityPlatelet-activating factor receptorHomo sapiens (human)
protein bindingPlatelet-activating factor receptorHomo sapiens (human)
phospholipid bindingPlatelet-activating factor receptorHomo sapiens (human)
mitogen-activated protein kinase bindingPlatelet-activating factor receptorHomo sapiens (human)
G protein-coupled purinergic nucleotide receptor activityPlatelet-activating factor receptorHomo sapiens (human)
phosphoprotein phosphatase activityM-phase inducer phosphatase 2Homo sapiens (human)
protein tyrosine phosphatase activityM-phase inducer phosphatase 2Homo sapiens (human)
protein bindingM-phase inducer phosphatase 2Homo sapiens (human)
protein kinase bindingM-phase inducer phosphatase 2Homo sapiens (human)
RNA bindingCaspase-7Homo sapiens (human)
aspartic-type endopeptidase activityCaspase-7Homo sapiens (human)
cysteine-type endopeptidase activityCaspase-7Homo sapiens (human)
protein bindingCaspase-7Homo sapiens (human)
peptidase activityCaspase-7Homo sapiens (human)
cysteine-type peptidase activityCaspase-7Homo sapiens (human)
cysteine-type endopeptidase activity involved in apoptotic processCaspase-7Homo sapiens (human)
cysteine-type endopeptidase activity involved in execution phase of apoptosisCaspase-7Homo sapiens (human)
endopeptidase activityDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
metalloendopeptidase activityDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
Notch bindingDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
interleukin-6 receptor bindingDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
integrin bindingDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
protein bindingDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
peptidase activityDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
metallopeptidase activityDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
SH3 domain bindingDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
cytokine bindingDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
PDZ domain bindingDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
tumor necrosis factor bindingDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
metal ion bindingDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
metalloendopeptidase activity involved in amyloid precursor protein catabolic processDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
peptidyl-prolyl cis-trans isomerase activityPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
cytoskeletal motor activityPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
protein bindingPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
beta-catenin bindingPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
cis-trans isomerase activityPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
mitogen-activated protein kinase kinase bindingPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
GTPase activating protein bindingPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
tau protein bindingPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
phosphoserine residue bindingPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
phosphothreonine residue bindingPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
phosphoprotein bindingPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
ubiquitin ligase activator activityPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
protein serine/threonine kinase activityAurora kinase BHomo sapiens (human)
protein serine/threonine kinase activityAurora kinase BHomo sapiens (human)
protein serine/threonine/tyrosine kinase activityAurora kinase BHomo sapiens (human)
protein bindingAurora kinase BHomo sapiens (human)
ATP bindingAurora kinase BHomo sapiens (human)
kinase bindingAurora kinase BHomo sapiens (human)
protein serine kinase activityAurora kinase BHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (79)

Processvia Protein(s)Taxonomy
spindle microtubuleAurora kinase AHomo sapiens (human)
nucleusAurora kinase AHomo sapiens (human)
nucleoplasmAurora kinase AHomo sapiens (human)
centrosomeAurora kinase AHomo sapiens (human)
centrioleAurora kinase AHomo sapiens (human)
spindleAurora kinase AHomo sapiens (human)
cytosolAurora kinase AHomo sapiens (human)
postsynaptic densityAurora kinase AHomo sapiens (human)
microtubule cytoskeletonAurora kinase AHomo sapiens (human)
basolateral plasma membraneAurora kinase AHomo sapiens (human)
midbodyAurora kinase AHomo sapiens (human)
spindle pole centrosomeAurora kinase AHomo sapiens (human)
ciliary basal bodyAurora kinase AHomo sapiens (human)
germinal vesicleAurora kinase AHomo sapiens (human)
axon hillockAurora kinase AHomo sapiens (human)
pronucleusAurora kinase AHomo sapiens (human)
perinuclear region of cytoplasmAurora kinase AHomo sapiens (human)
mitotic spindleAurora kinase AHomo sapiens (human)
meiotic spindleAurora kinase AHomo sapiens (human)
mitotic spindle poleAurora kinase AHomo sapiens (human)
glutamatergic synapseAurora kinase AHomo sapiens (human)
spindle pole centrosomeAurora kinase AHomo sapiens (human)
chromosome passenger complexAurora kinase AHomo sapiens (human)
spindle midzoneAurora kinase AHomo sapiens (human)
kinetochoreAurora kinase AHomo sapiens (human)
nucleusPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
cytosolPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
cytoskeletonPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
plasma membranePolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
adherens junctionPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
focal adhesionPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
membranePolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
extracellular exosomePolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
plasma membraneTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
stereocilium bundleTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
glutamatergic synapseIntegrin beta-3Homo sapiens (human)
nucleusIntegrin beta-3Homo sapiens (human)
nucleoplasmIntegrin beta-3Homo sapiens (human)
plasma membraneIntegrin beta-3Homo sapiens (human)
cell-cell junctionIntegrin beta-3Homo sapiens (human)
focal adhesionIntegrin beta-3Homo sapiens (human)
external side of plasma membraneIntegrin beta-3Homo sapiens (human)
cell surfaceIntegrin beta-3Homo sapiens (human)
apical plasma membraneIntegrin beta-3Homo sapiens (human)
platelet alpha granule membraneIntegrin beta-3Homo sapiens (human)
lamellipodium membraneIntegrin beta-3Homo sapiens (human)
filopodium membraneIntegrin beta-3Homo sapiens (human)
microvillus membraneIntegrin beta-3Homo sapiens (human)
ruffle membraneIntegrin beta-3Homo sapiens (human)
integrin alphav-beta3 complexIntegrin beta-3Homo sapiens (human)
melanosomeIntegrin beta-3Homo sapiens (human)
synapseIntegrin beta-3Homo sapiens (human)
postsynaptic membraneIntegrin beta-3Homo sapiens (human)
extracellular exosomeIntegrin beta-3Homo sapiens (human)
integrin alphaIIb-beta3 complexIntegrin beta-3Homo sapiens (human)
glycinergic synapseIntegrin beta-3Homo sapiens (human)
integrin complexIntegrin beta-3Homo sapiens (human)
protein-containing complexIntegrin beta-3Homo sapiens (human)
alphav-beta3 integrin-PKCalpha complexIntegrin beta-3Homo sapiens (human)
alphav-beta3 integrin-IGF-1-IGF1R complexIntegrin beta-3Homo sapiens (human)
alphav-beta3 integrin-HMGB1 complexIntegrin beta-3Homo sapiens (human)
receptor complexIntegrin beta-3Homo sapiens (human)
alphav-beta3 integrin-vitronectin complexIntegrin beta-3Homo sapiens (human)
alpha9-beta1 integrin-ADAM8 complexIntegrin beta-3Homo sapiens (human)
focal adhesionIntegrin beta-3Homo sapiens (human)
cell surfaceIntegrin beta-3Homo sapiens (human)
synapseIntegrin beta-3Homo sapiens (human)
plasma membraneIntegrin alpha-IIbHomo sapiens (human)
focal adhesionIntegrin alpha-IIbHomo sapiens (human)
cell surfaceIntegrin alpha-IIbHomo sapiens (human)
platelet alpha granule membraneIntegrin alpha-IIbHomo sapiens (human)
extracellular exosomeIntegrin alpha-IIbHomo sapiens (human)
integrin alphaIIb-beta3 complexIntegrin alpha-IIbHomo sapiens (human)
blood microparticleIntegrin alpha-IIbHomo sapiens (human)
integrin complexIntegrin alpha-IIbHomo sapiens (human)
external side of plasma membraneIntegrin alpha-IIbHomo sapiens (human)
nuclear chromosomeDNA topoisomerase 1Homo sapiens (human)
P-bodyDNA topoisomerase 1Homo sapiens (human)
fibrillar centerDNA topoisomerase 1Homo sapiens (human)
male germ cell nucleusDNA topoisomerase 1Homo sapiens (human)
nucleusDNA topoisomerase 1Homo sapiens (human)
nucleoplasmDNA topoisomerase 1Homo sapiens (human)
nucleolusDNA topoisomerase 1Homo sapiens (human)
perikaryonDNA topoisomerase 1Homo sapiens (human)
protein-DNA complexDNA topoisomerase 1Homo sapiens (human)
nucleolusDNA topoisomerase 1Homo sapiens (human)
cytosolIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
smooth muscle contractile fiberIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
stereocilium bundleIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
cytoplasmIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
plasma membraneGamma-aminobutyric acid receptor subunit gamma-2Rattus norvegicus (Norway rat)
plasma membraneGlutamate receptor 1Rattus norvegicus (Norway rat)
plasma membraneGlutamate receptor 2Rattus norvegicus (Norway rat)
mitochondrionAmine oxidase [flavin-containing] AHomo sapiens (human)
mitochondrial outer membraneAmine oxidase [flavin-containing] AHomo sapiens (human)
cytosolAmine oxidase [flavin-containing] AHomo sapiens (human)
mitochondrionAmine oxidase [flavin-containing] AHomo sapiens (human)
plasma membranePlatelet-activating factor receptorHomo sapiens (human)
membranePlatelet-activating factor receptorHomo sapiens (human)
secretory granule membranePlatelet-activating factor receptorHomo sapiens (human)
tertiary granule membranePlatelet-activating factor receptorHomo sapiens (human)
spindle poleM-phase inducer phosphatase 2Homo sapiens (human)
nucleoplasmM-phase inducer phosphatase 2Homo sapiens (human)
centrosomeM-phase inducer phosphatase 2Homo sapiens (human)
cytosolM-phase inducer phosphatase 2Homo sapiens (human)
nucleusM-phase inducer phosphatase 2Homo sapiens (human)
cytoplasmM-phase inducer phosphatase 2Homo sapiens (human)
extracellular spaceCaspase-7Homo sapiens (human)
nucleusCaspase-7Homo sapiens (human)
cytoplasmCaspase-7Homo sapiens (human)
cytosolCaspase-7Homo sapiens (human)
nucleusCaspase-7Homo sapiens (human)
nucleoplasmCaspase-7Homo sapiens (human)
cytosolCaspase-7Homo sapiens (human)
plasma membraneGamma-aminobutyric acid receptor subunit alpha-1Rattus norvegicus (Norway rat)
plasma membraneGamma-aminobutyric acid receptor subunit beta-2Rattus norvegicus (Norway rat)
cell-cell junctionDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
focal adhesionDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
ruffle membraneDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
Golgi membraneDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
cytoplasmDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
endoplasmic reticulum lumenDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
cytosolDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
plasma membraneDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
cell surfaceDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
actin cytoskeletonDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
membraneDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
apical plasma membraneDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
membrane raftDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
plasma membraneDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
glutamatergic synapsePeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
postsynaptic cytosolPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
nucleusPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
nucleoplasmPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
cytoplasmPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
cytosolPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
nuclear speckPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
midbodyPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
ciliary basal bodyPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
nucleusPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
cytosolPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
kinetochoreAurora kinase BHomo sapiens (human)
condensed chromosome, centromeric regionAurora kinase BHomo sapiens (human)
nucleusAurora kinase BHomo sapiens (human)
nucleoplasmAurora kinase BHomo sapiens (human)
spindleAurora kinase BHomo sapiens (human)
cytosolAurora kinase BHomo sapiens (human)
chromocenterAurora kinase BHomo sapiens (human)
microtubule cytoskeletonAurora kinase BHomo sapiens (human)
midbodyAurora kinase BHomo sapiens (human)
chromosome passenger complexAurora kinase BHomo sapiens (human)
mitotic spindle poleAurora kinase BHomo sapiens (human)
mitotic spindle midzoneAurora kinase BHomo sapiens (human)
kinetochoreAurora kinase BHomo sapiens (human)
spindle pole centrosomeAurora kinase BHomo sapiens (human)
spindle microtubuleAurora kinase BHomo sapiens (human)
spindle midzoneAurora kinase BHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (192)

Assay IDTitleYearJournalArticle
AID1801570MAO Inhibition Assay from Article 10.1111/cbdd.12708: \\Evaluation of Natural and Synthetic 1,4-naphthoquinones as Inhibitors of Monoamine Oxidase.\\2016Chemical biology & drug design, May, Volume: 87, Issue:5
Evaluation of Natural and Synthetic 1,4-naphthoquinones as Inhibitors of Monoamine Oxidase.
AID1801643FabZ Inhibition Assay from Article 10.1021/acs.biochem.5b00832: \\u00DF-Hydroxyacyl-acyl Carrier Protein Dehydratase (FabZ) from Francisella tularensis and Yersinia pestis: Structure Determination, Enzymatic Characterization, and Cross-Inhibition Studies.\\2016Biochemistry, Feb-23, Volume: 55, Issue:7
β-Hydroxyacyl-acyl Carrier Protein Dehydratase (FabZ) from Francisella tularensis and Yersinia pestis: Structure Determination, Enzymatic Characterization, and Cross-Inhibition Studies.
AID1798473Enzyme Inhibition Assay from Article 10.1021/jm7014155: \\Indoleamine 2,3-dioxygenase is the anticancer target for a novel series of potent naphthoquinone-based inhibitors.\\2008Journal of medicinal chemistry, Mar-27, Volume: 51, Issue:6
Indoleamine 2,3-dioxygenase is the anticancer target for a novel series of potent naphthoquinone-based inhibitors.
AID752853Induction of apoptosis in human LNCAP cells assessed as decrease of androgen receptor protein expression at 5 uM after 24 hrs by Western blot analysis2013Bioorganic & medicinal chemistry letters, Jun-15, Volume: 23, Issue:12
Juglone, isolated from Juglans mandshurica Maxim, induces apoptosis via down-regulation of AR expression in human prostate cancer LNCaP cells.
AID1625338Increase in calcium level in HEK293 cells at 20 uM by fura2/AM dye based single cell based plate reader analysis2016Journal of natural products, Apr-22, Volume: 79, Issue:4
Plumbagin, Juglone, and Boropinal as Novel TRPA1 Agonists.
AID417088Inhibition of histidine-tagged rat recombinant MKP3 catalytic domain expressed in Escherichia coli BL21(DE3)2009Bioorganic & medicinal chemistry, Mar-15, Volume: 17, Issue:6
Bioactivities of simplified adociaquinone B and naphthoquinone derivatives against Cdc25B, MKP-1, and MKP-3 phosphatases.
AID628060Inhibition of recombinant His-tagged human DNA polymerase lambda using poly(dA)/oligo(dT)18 (A/T = 2/1) and dTTP as the DNA template-primer and nucleotide substrate at 10 uM after 60 mins2011Bioorganic & medicinal chemistry, Oct-01, Volume: 19, Issue:19
Inhibitory effect of novel 5-O-acyl juglones on mammalian DNA polymerase activity, cancer cell growth and inflammatory response.
AID476715Growth inhibition of human SW1573 cells after 48 hrs by sulforhodamine B assay2010Bioorganic & medicinal chemistry, Apr-01, Volume: 18, Issue:7
Antiproliferative activity of synthetic naphthoquinones related to lapachol. First synthesis of 5-hydroxylapachol.
AID326467Inhibition of purified human recombinant IDO2008Journal of medicinal chemistry, Mar-27, Volume: 51, Issue:6
Indoleamine 2,3-dioxygenase is the anticancer target for a novel series of potent naphthoquinone-based inhibitors.
AID1625343Activation of human TRPA1 expressed in HEK293 cells assessed as induction of outward current at 10 uM at -70 to +70 mV by whole cell patch clamp assay2016Journal of natural products, Apr-22, Volume: 79, Issue:4
Plumbagin, Juglone, and Boropinal as Novel TRPA1 Agonists.
AID1156518Cytotoxicity against human HeLa cells assessed as inhibition of cell viability after 48 hrs by MTT assay2014European journal of medicinal chemistry, Aug-18, Volume: 83Synthesis and anticancer activity of some novel 5,6-fused hybrids of juglone based 1,4-naphthoquinones.
AID1083183Bactericidal activity against Pseudomonas fluorescens A506 assessed as growth inhibition at pH 7.2 by suspension culture assay2012Journal of agricultural and food chemistry, Dec-12, Volume: 60, Issue:49
Potent and specific bactericidal effect of juglone (5-hydroxy-1,4-naphthoquinone) on the fire blight pathogen Erwinia amylovora.
AID1271958Growth inhibition of mouse B16F10 cells by MTT assay2016Bioorganic & medicinal chemistry letters, Jan-15, Volume: 26, Issue:2
Novel juglone and plumbagin 5-O derivatives and their in vitro growth inhibitory activity against apoptosis-resistant cancer cells.
AID1625339Activation of human TRPA1 expressed in HEK293 cells assessed as increase in calcium level by fluo-4 dye based plate reader analysis2016Journal of natural products, Apr-22, Volume: 79, Issue:4
Plumbagin, Juglone, and Boropinal as Novel TRPA1 Agonists.
AID1125076Cytotoxicity against human HeLa cells assessed as inhibition of number of colonies formed in soft agar after 14 days by microscopic analysis2014European journal of medicinal chemistry, Apr-22, Volume: 77Quinone-carbohydrate nonglucoside conjugates as a new type of cytotoxic agents: synthesis and determination of in vitro activity.
AID1179571Antifungal activity against fluconazole-resistant Candida albicans at 100 ug/well after 24 hrs by well diffusion assay2014Bioorganic & medicinal chemistry letters, Aug-01, Volume: 24, Issue:15
Synthesis and SAR study of novel anticancer and antimicrobial naphthoquinone amide derivatives.
AID1083193Bactericidal activity against Erwinia amylovora 872 assessed as growth inhibition at pH 7.2 by suspension culture assay2012Journal of agricultural and food chemistry, Dec-12, Volume: 60, Issue:49
Potent and specific bactericidal effect of juglone (5-hydroxy-1,4-naphthoquinone) on the fire blight pathogen Erwinia amylovora.
AID417087Inhibition of histidine-tagged mouse MKP1 catalytic domain expressed in human Hela cells2009Bioorganic & medicinal chemistry, Mar-15, Volume: 17, Issue:6
Bioactivities of simplified adociaquinone B and naphthoquinone derivatives against Cdc25B, MKP-1, and MKP-3 phosphatases.
AID336953Inhibition of TPA-induced EBV-early antigen activation in human Raji cells at 1000 molar ratio after 48 hrs by indirect immunofluorescence technique relative to TPA
AID336955Inhibition of TPA-induced EBV-early antigen activation in human Raji cells at 100 molar ratio after 48 hrs by indirect immunofluorescence technique relative to TPA
AID1179573Antifungal activity against fluconazole-resistant Candida albicans by NCCLS method2014Bioorganic & medicinal chemistry letters, Aug-01, Volume: 24, Issue:15
Synthesis and SAR study of novel anticancer and antimicrobial naphthoquinone amide derivatives.
AID322956Inhibition of synthetic amyloid beta42 oligomer formation by Western blot2007The Journal of biological chemistry, Apr-06, Volume: 282, Issue:14
Small molecule inhibitors of aggregation indicate that amyloid beta oligomerization and fibrillization pathways are independent and distinct.
AID501585Antiparasitic activity against Trichomonas vaginalis T1 at 100 uM after 24 hrs by hemocytometric analysis2010Bioorganic & medicinal chemistry letters, Sep-01, Volume: 20, Issue:17
Preliminary studies of 3,4-dichloroaniline amides as antiparasitic agents: structure-activity analysis of a compound library in vitro against Trichomonas vaginalis.
AID627976Cytotoxicity against human HCT116 cells by WST-1 assay2011Bioorganic & medicinal chemistry, Oct-01, Volume: 19, Issue:19
Inhibitory effect of novel 5-O-acyl juglones on mammalian DNA polymerase activity, cancer cell growth and inflammatory response.
AID336960Cytotoxicity against human Raji cells assessed as cell viability at 10 molar ratio
AID1181944Glutathione reactivity at 1 mM in presence of 1 mM glutathione containing PBS and 1 mM EDTA buffer at pH 7.4 assessed as remaining GSH level after 30 mins by spectrophotometry by Ellman's method2014Bioorganic & medicinal chemistry, Aug-01, Volume: 22, Issue:15
Benzoquinones as inhibitors of botulinum neurotoxin serotype A.
AID1594145Inhibition of Escherichia coli GroEL expressed in Escherichia coli DH5alpha/Escherichia coli GroES expressed in Escherichia coli BL21 (DE3) assessed as reduction in GroEL/GroES-mediated denatured rhodanese refolding by measuring rhodanese enzyme activity 2019Bioorganic & medicinal chemistry letters, 05-01, Volume: 29, Issue:9
HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules.
AID1083199Bactericidal activity against Erwinia amylovora 782 assessed as growth inhibition at pH 7.2 by suspension culture assay2012Journal of agricultural and food chemistry, Dec-12, Volume: 60, Issue:49
Potent and specific bactericidal effect of juglone (5-hydroxy-1,4-naphthoquinone) on the fire blight pathogen Erwinia amylovora.
AID1179569Antibacterial activity against methicillin-resistant Staphylococcus aureus at 100 ug/well after 24 hrs by well diffusion assay2014Bioorganic & medicinal chemistry letters, Aug-01, Volume: 24, Issue:15
Synthesis and SAR study of novel anticancer and antimicrobial naphthoquinone amide derivatives.
AID322958Inhibition of synthetic amyloid beta-42 fibrillation by light scattering analysis relative to control2007The Journal of biological chemistry, Apr-06, Volume: 282, Issue:14
Small molecule inhibitors of aggregation indicate that amyloid beta oligomerization and fibrillization pathways are independent and distinct.
AID1832336Inhibition of SARS-CoV-2 main protease at 1 uM relative to control2021European journal of medicinal chemistry, Dec-05, Volume: 225Discovery of juglone and its derivatives as potent SARS-CoV-2 main proteinase inhibitors.
AID476716Growth inhibition of human T47D cells after 48 hrs by sulforhodamine B assay2010Bioorganic & medicinal chemistry, Apr-01, Volume: 18, Issue:7
Antiproliferative activity of synthetic naphthoquinones related to lapachol. First synthesis of 5-hydroxylapachol.
AID1464037Inhibition of Pin1 (unknown origin) assessed as reduction in peptidyl-prolyl isomerase activity at 10 uM incubated for 30 mins using Suc-Ala-Glu-cis-Pro-Phe-4-nitroanilide substrate by protease coupled assay2017Bioorganic & medicinal chemistry, 10-15, Volume: 25, Issue:20
Conjugates of 18β-glycyrrhetinic acid derivatives with 3-(1H-benzo[d]imidazol-2-yl)propanoic acid as Pin1 inhibitors displaying anti-prostate cancer ability.
AID752854Induction of apoptosis in human LNCAP cells assessed as decrease of prostate-specific antigen protein expression after 24 hrs by Western blot analysis2013Bioorganic & medicinal chemistry letters, Jun-15, Volume: 23, Issue:12
Juglone, isolated from Juglans mandshurica Maxim, induces apoptosis via down-regulation of AR expression in human prostate cancer LNCaP cells.
AID1083209Bactericidal activity against Erwinia amylovora 295/93 assessed as growth inhibition at 2.5 uM at pH 4.0 to 8.0 by suspension culture assay2012Journal of agricultural and food chemistry, Dec-12, Volume: 60, Issue:49
Potent and specific bactericidal effect of juglone (5-hydroxy-1,4-naphthoquinone) on the fire blight pathogen Erwinia amylovora.
AID627975Cytotoxicity against human HCT116 cells at 100 uM by WST-1 assay2011Bioorganic & medicinal chemistry, Oct-01, Volume: 19, Issue:19
Inhibitory effect of novel 5-O-acyl juglones on mammalian DNA polymerase activity, cancer cell growth and inflammatory response.
AID1083190Bactericidal activity against Erwinia pyrifoliae 4171 assessed as growth inhibition at pH 7.2 by suspension culture assay2012Journal of agricultural and food chemistry, Dec-12, Volume: 60, Issue:49
Potent and specific bactericidal effect of juglone (5-hydroxy-1,4-naphthoquinone) on the fire blight pathogen Erwinia amylovora.
AID1544555Inhibition of N-terminal 6-His tagged full length Pin1 (unknown origin) expressed in Escherichia coli at 10 uM using Suc-AEPF-pNA as substrate preincubated for 10 mins followed by substrate addition and measured for 180 secs by spectrophotometry relative 2019Bioorganic & medicinal chemistry, 06-01, Volume: 27, Issue:11
Discovery of 4,6-bis(benzyloxy)-3-phenylbenzofuran as a novel Pin1 inhibitor to suppress hepatocellular carcinoma via upregulating microRNA biogenesis.
AID752858Induction of apoptosis in human LNCAP cells assessed as cleavage of precursor of caspase-3 and 9 after 24 hrs by Western blot analysis2013Bioorganic & medicinal chemistry letters, Jun-15, Volume: 23, Issue:12
Juglone, isolated from Juglans mandshurica Maxim, induces apoptosis via down-regulation of AR expression in human prostate cancer LNCaP cells.
AID627879Inhibition of C-terminal His6-tagged human DNA polymerase kappa (amino acids 1 to 560) using bovine deoxyribonuclease 1-treated DNA and dNTP as the DNA template-primer and nucleotide substrate at 10 uM after 60 mins2011Bioorganic & medicinal chemistry, Oct-01, Volume: 19, Issue:19
Inhibitory effect of novel 5-O-acyl juglones on mammalian DNA polymerase activity, cancer cell growth and inflammatory response.
AID627877Inhibition of calf DNA polymerase alpha using bovine deoxyribonuclease 1-treated DNA and dNTP as the DNA template-primer and nucleotide substrate at 10 uM after 60 mins2011Bioorganic & medicinal chemistry, Oct-01, Volume: 19, Issue:19
Inhibitory effect of novel 5-O-acyl juglones on mammalian DNA polymerase activity, cancer cell growth and inflammatory response.
AID231071Peroxidant property was expressed as ratio of uMol of malondialdehyde and mMol of deoxyribose released by 75 uM test compound1997Journal of medicinal chemistry, Nov-07, Volume: 40, Issue:23
Simple analogues of anthralin: unusual specificity of structure and antiproliferative activity.
AID1179572Antibacterial activity against methicillin-resistant Staphylococcus aureus by NCCLS method2014Bioorganic & medicinal chemistry letters, Aug-01, Volume: 24, Issue:15
Synthesis and SAR study of novel anticancer and antimicrobial naphthoquinone amide derivatives.
AID627981Cytotoxicity against mouse RAW264.7 cells2011Bioorganic & medicinal chemistry, Oct-01, Volume: 19, Issue:19
Inhibitory effect of novel 5-O-acyl juglones on mammalian DNA polymerase activity, cancer cell growth and inflammatory response.
AID1625341Activation of human TRPA1 expressed in HEK293 cells assessed as increase in calcium level at 20 uM by fura2/AM dye based single cell based plate reader analysis2016Journal of natural products, Apr-22, Volume: 79, Issue:4
Plumbagin, Juglone, and Boropinal as Novel TRPA1 Agonists.
AID228426Inhibition of topoisomerase I1998Bioorganic & medicinal chemistry letters, Dec-01, Volume: 8, Issue:23
Inhibition of topoisomerase I by naphthoquinone derivatives.
AID1156517Cytotoxicity against human MCF7 cells assessed as inhibition of cell viability after 48 hrs by MTT assay2014European journal of medicinal chemistry, Aug-18, Volume: 83Synthesis and anticancer activity of some novel 5,6-fused hybrids of juglone based 1,4-naphthoquinones.
AID1083185Bactericidal activity against Pectobacterium carotovorum NCPB 312 assessed as growth inhibition at pH 7.2 by suspension culture assay2012Journal of agricultural and food chemistry, Dec-12, Volume: 60, Issue:49
Potent and specific bactericidal effect of juglone (5-hydroxy-1,4-naphthoquinone) on the fire blight pathogen Erwinia amylovora.
AID1156521Cytotoxicity against human PC3 cells assessed as inhibition of cell viability after 48 hrs by MTT assay2014European journal of medicinal chemistry, Aug-18, Volume: 83Synthesis and anticancer activity of some novel 5,6-fused hybrids of juglone based 1,4-naphthoquinones.
AID1083174Activity of Agaricus bisporus (mushroom) tyrosinase assessed as drug oxidation by photometric analysis2012Journal of agricultural and food chemistry, Dec-12, Volume: 60, Issue:49
Potent and specific bactericidal effect of juglone (5-hydroxy-1,4-naphthoquinone) on the fire blight pathogen Erwinia amylovora.
AID1125074Cytotoxicity against human HeLa cells assessed as cell viability after 48 hrs by MTS assay2014European journal of medicinal chemistry, Apr-22, Volume: 77Quinone-carbohydrate nonglucoside conjugates as a new type of cytotoxic agents: synthesis and determination of in vitro activity.
AID627982Antiinflammatory activity in mouse assessed as inhibition of TPA-induced mouse ear edema at 500 ug/ear administered 30 mins before TPA challenge measured after 7 hrs relative to untreated control2011Bioorganic & medicinal chemistry, Oct-01, Volume: 19, Issue:19
Inhibitory effect of novel 5-O-acyl juglones on mammalian DNA polymerase activity, cancer cell growth and inflammatory response.
AID1148352Tumor promoting activity in ICR/Ha Swiss mouse at 62 ug administered three times a week measured for 370 days1978Journal of medicinal chemistry, Jan, Volume: 21, Issue:1
Structure and tumor-promoting activity of analogues of anthralin (1,8-dihydroxy-9-anthrone).
AID1869321Antiproliferative activity against human HCC1954 cells measured after 72 hrs by SRB assay2022Journal of natural products, 06-24, Volume: 85, Issue:6
Identification and Characterization of Natural and Semisynthetic Quinones as Aurora Kinase Inhibitors.
AID85486Cytotoxic activity (2 uM) was measured by the amount of LDH (mU) release in HaCaT cells.1997Journal of medicinal chemistry, Nov-07, Volume: 40, Issue:23
Simple analogues of anthralin: unusual specificity of structure and antiproliferative activity.
AID476717Growth inhibition of human WiDr cells after 48 hrs by sulforhodamine B assay2010Bioorganic & medicinal chemistry, Apr-01, Volume: 18, Issue:7
Antiproliferative activity of synthetic naphthoquinones related to lapachol. First synthesis of 5-hydroxylapachol.
AID1083182Bactericidal activity against Escherichia coli assessed as growth inhibition at pH 7.2 by suspension culture assay2012Journal of agricultural and food chemistry, Dec-12, Volume: 60, Issue:49
Potent and specific bactericidal effect of juglone (5-hydroxy-1,4-naphthoquinone) on the fire blight pathogen Erwinia amylovora.
AID1083173Bactericidal activity against Erwinia amylovora 295/93 assessed as colony growth inhibition at 25 uM at pH 4.5 by plating assay in presence of 0.5 mg/l mushroom tyrosinase2012Journal of agricultural and food chemistry, Dec-12, Volume: 60, Issue:49
Potent and specific bactericidal effect of juglone (5-hydroxy-1,4-naphthoquinone) on the fire blight pathogen Erwinia amylovora.
AID752862Induction of apoptosis in human LNCAP cells assessed as nuclear condensation at 5 to 15 uM after 24 hrs using Hoechst 33342 staining by fluorescence microscopic analysis2013Bioorganic & medicinal chemistry letters, Jun-15, Volume: 23, Issue:12
Juglone, isolated from Juglans mandshurica Maxim, induces apoptosis via down-regulation of AR expression in human prostate cancer LNCaP cells.
AID1605075-LO inhibitory activity was determined by inhibition of LTB4 biosynthesis in bovine polymorphonuclear leukocytes (PMNL)1997Journal of medicinal chemistry, Nov-07, Volume: 40, Issue:23
Simple analogues of anthralin: unusual specificity of structure and antiproliferative activity.
AID1869315Inhibition of Aurora B (unknown origin)2022Journal of natural products, 06-24, Volume: 85, Issue:6
Identification and Characterization of Natural and Semisynthetic Quinones as Aurora Kinase Inhibitors.
AID1083181Bactericidal activity against Erwinia amylovora 295/93 at 10 uM after 30 min2012Journal of agricultural and food chemistry, Dec-12, Volume: 60, Issue:49
Potent and specific bactericidal effect of juglone (5-hydroxy-1,4-naphthoquinone) on the fire blight pathogen Erwinia amylovora.
AID1156520Cytotoxicity against human MDA-MB-231 cells assessed as inhibition of cell viability after 48 hrs by MTT assay2014European journal of medicinal chemistry, Aug-18, Volume: 83Synthesis and anticancer activity of some novel 5,6-fused hybrids of juglone based 1,4-naphthoquinones.
AID1271957Growth inhibition of human SK-MEL-28 cells by MTT assay2016Bioorganic & medicinal chemistry letters, Jan-15, Volume: 26, Issue:2
Novel juglone and plumbagin 5-O derivatives and their in vitro growth inhibitory activity against apoptosis-resistant cancer cells.
AID1869314Inhibition of Aurora A (unknown origin)2022Journal of natural products, 06-24, Volume: 85, Issue:6
Identification and Characterization of Natural and Semisynthetic Quinones as Aurora Kinase Inhibitors.
AID1420354Inhibition of recombinant N-terminal His6-tagged human Pin1 at 10 uM using Suc-Ala-Glu-cis-Pro-Phe-4-nitroanilide as substrate preincubated for 30 mins followed by substrate addition measured for 90 secs2018Bioorganic & medicinal chemistry letters, 10-15, Volume: 28, Issue:19
Design, synthesis and biological evaluation of ring A modified 11-keto-boswellic acid derivatives as Pin1 inhibitors with remarkable anti-prostate cancer activity.
AID1869325Antiproliferative activity against human MV4-11 cells measured after 72 hrs by SRB assay2022Journal of natural products, 06-24, Volume: 85, Issue:6
Identification and Characterization of Natural and Semisynthetic Quinones as Aurora Kinase Inhibitors.
AID752859Induction of apoptosis in human LNCAP cells assessed as increase of annexin V-FITC/PI staining positive cells after 24 hrs by flow cytometry2013Bioorganic & medicinal chemistry letters, Jun-15, Volume: 23, Issue:12
Juglone, isolated from Juglans mandshurica Maxim, induces apoptosis via down-regulation of AR expression in human prostate cancer LNCaP cells.
AID1181939Inhibition of recombinant Clostridium botulinum neurotoxin serotype A light chain assessed as Kinact to KI ratio at 50 uM after 1.5 hrs by SNAPtide FRET based assay2014Bioorganic & medicinal chemistry, Aug-01, Volume: 22, Issue:15
Benzoquinones as inhibitors of botulinum neurotoxin serotype A.
AID1464038Inhibition of Pin1 (unknown origin) assessed as reduction in peptidyl-prolyl isomerase activity incubated for 30 mins using Suc-Ala-Glu-cis-Pro-Phe-4-nitroanilide substrate by protease coupled assay2017Bioorganic & medicinal chemistry, 10-15, Volume: 25, Issue:20
Conjugates of 18β-glycyrrhetinic acid derivatives with 3-(1H-benzo[d]imidazol-2-yl)propanoic acid as Pin1 inhibitors displaying anti-prostate cancer ability.
AID1869328Antiproliferative activity against human CAL-51 cells measured after 72 hrs by SRB assay2022Journal of natural products, 06-24, Volume: 85, Issue:6
Identification and Characterization of Natural and Semisynthetic Quinones as Aurora Kinase Inhibitors.
AID1758986Cytotoxicity against human HeLa cells2021Bioorganic & medicinal chemistry letters, 06-01, Volume: 41Synthesis, biological evaluation, and correlation of cytotoxicity versus redox potential of 1,4-naphthoquinone derivatives.
AID336957Cytotoxicity against human Raji cells assessed as cell viability at 1000 molar ratio
AID1083176Bactericidal activity against Erwinia amylovora 295/93 assessed as growth inhibition at 10 uM preincubated for 1 hr with visible light by suspension culture assay2012Journal of agricultural and food chemistry, Dec-12, Volume: 60, Issue:49
Potent and specific bactericidal effect of juglone (5-hydroxy-1,4-naphthoquinone) on the fire blight pathogen Erwinia amylovora.
AID1083188Bactericidal activity against Erwinia billingiae 6830 assessed as growth inhibition at pH 7.2 by suspension culture assay2012Journal of agricultural and food chemistry, Dec-12, Volume: 60, Issue:49
Potent and specific bactericidal effect of juglone (5-hydroxy-1,4-naphthoquinone) on the fire blight pathogen Erwinia amylovora.
AID1869326Antiproliferative activity against human K562 cells measured after 72 hrs by SRB assay2022Journal of natural products, 06-24, Volume: 85, Issue:6
Identification and Characterization of Natural and Semisynthetic Quinones as Aurora Kinase Inhibitors.
AID752852Induction of apoptosis in human LNCAP cells assessed as decrease of prostate-specific antigen protein expression at 5 uM after 24 hrs by Western blot analysis2013Bioorganic & medicinal chemistry letters, Jun-15, Volume: 23, Issue:12
Juglone, isolated from Juglans mandshurica Maxim, induces apoptosis via down-regulation of AR expression in human prostate cancer LNCaP cells.
AID1156519Cytotoxicity against human MDA-MB-453 cells assessed as inhibition of cell viability after 48 hrs by MTT assay2014European journal of medicinal chemistry, Aug-18, Volume: 83Synthesis and anticancer activity of some novel 5,6-fused hybrids of juglone based 1,4-naphthoquinones.
AID336954Inhibition of TPA-induced EBV-early antigen activation in human Raji cells at 500 molar ratio after 48 hrs by indirect immunofluorescence technique relative to TPA
AID763573Binding affinity to STAT3 SH2 domain (unknown origin) using 5-FAM-SpYLPQTV as probe assessed as inhibition of protein dimerization at 500 uM after 60 mins by fluorescence polarization assay relative to control2013Bioorganic & medicinal chemistry, Aug-01, Volume: 21, Issue:15
Anticancer activity and SAR studies of substituted 1,4-naphthoquinones.
AID1083179Bactericidal activity against mixture of two strains of Erwinia amylovora 295/93 and 763 inoculated in Malus x domestica cv. Gala flowers assessed as prevention of infection at 0.01 mM applied two times at 2 hr after bacterial exposure measured after 8 to2012Journal of agricultural and food chemistry, Dec-12, Volume: 60, Issue:49
Potent and specific bactericidal effect of juglone (5-hydroxy-1,4-naphthoquinone) on the fire blight pathogen Erwinia amylovora.
AID322957Inhibition of synthetic amyloid beta-42 fibrillation by ThT fluorescence analysis relative to control2007The Journal of biological chemistry, Apr-06, Volume: 282, Issue:14
Small molecule inhibitors of aggregation indicate that amyloid beta oligomerization and fibrillization pathways are independent and distinct.
AID1179570Antibacterial activity against Pseudomonas aeruginosa MTCC 201 at 100 ug/well after 24 hrs by well diffusion assay2014Bioorganic & medicinal chemistry letters, Aug-01, Volume: 24, Issue:15
Synthesis and SAR study of novel anticancer and antimicrobial naphthoquinone amide derivatives.
AID1083202Bactericidal activity against Erwinia amylovora 562 assessed as growth inhibition at pH 7.2 by suspension culture assay2012Journal of agricultural and food chemistry, Dec-12, Volume: 60, Issue:49
Potent and specific bactericidal effect of juglone (5-hydroxy-1,4-naphthoquinone) on the fire blight pathogen Erwinia amylovora.
AID977599Inhibition of sodium fluorescein uptake in OATP1B1-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID1625340Increase in calcium level in HEK293 cells at 0.1 to 100 uM by fluo-4 dye based plate reader analysis2016Journal of natural products, Apr-22, Volume: 79, Issue:4
Plumbagin, Juglone, and Boropinal as Novel TRPA1 Agonists.
AID1083180Bactericidal activity against 2x10'8 CFU/mL Erwinia amylovora 295/93 cells assessed as late restarting of growth from surviving cells at <10 uM by suspension culture assay2012Journal of agricultural and food chemistry, Dec-12, Volume: 60, Issue:49
Potent and specific bactericidal effect of juglone (5-hydroxy-1,4-naphthoquinone) on the fire blight pathogen Erwinia amylovora.
AID752850Induction of apoptosis in human LNCAP cells assessed as decrease of DHT-induced prostate-specific antigen mRNA expression at 15 uM treated 2 hrs before DHT challenge measured after 24 hrs by RT-PCR analysis2013Bioorganic & medicinal chemistry letters, Jun-15, Volume: 23, Issue:12
Juglone, isolated from Juglans mandshurica Maxim, induces apoptosis via down-regulation of AR expression in human prostate cancer LNCaP cells.
AID1420355Inhibition of recombinant N-terminal His6-tagged human Pin1 using Suc-Ala-Glu-cis-Pro-Phe-4-nitroanilide as substrate preincubated for 30 mins followed by substrate addition measured for 90 secs2018Bioorganic & medicinal chemistry letters, 10-15, Volume: 28, Issue:19
Design, synthesis and biological evaluation of ring A modified 11-keto-boswellic acid derivatives as Pin1 inhibitors with remarkable anti-prostate cancer activity.
AID1869327Antiproliferative activity against human BT-549 cells measured after 72 hrs by SRB assay2022Journal of natural products, 06-24, Volume: 85, Issue:6
Identification and Characterization of Natural and Semisynthetic Quinones as Aurora Kinase Inhibitors.
AID763580Cytotoxicity against human DU145 cells assessed as growth inhibition after 72 hrs by MTS assay2013Bioorganic & medicinal chemistry, Aug-01, Volume: 21, Issue:15
Anticancer activity and SAR studies of substituted 1,4-naphthoquinones.
AID627979Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced TNFalpha secretion at 5 uM treated 30 mins before LPS challenge measured after 24 hrs by ELISA2011Bioorganic & medicinal chemistry, Oct-01, Volume: 19, Issue:19
Inhibitory effect of novel 5-O-acyl juglones on mammalian DNA polymerase activity, cancer cell growth and inflammatory response.
AID85482Antiproliferative (inhibition of cell growth) activity against HaCaT cells (human keratinocyte line)1997Journal of medicinal chemistry, Nov-07, Volume: 40, Issue:23
Simple analogues of anthralin: unusual specificity of structure and antiproliferative activity.
AID1083207Bactericidal activity against Erwinia amylovora 295/93 assessed as inhibition of bacterial growth under infection conditions in hrp gene expression inducing medium at pH 7.0 after overnight incubation by suspension culture assay2012Journal of agricultural and food chemistry, Dec-12, Volume: 60, Issue:49
Potent and specific bactericidal effect of juglone (5-hydroxy-1,4-naphthoquinone) on the fire blight pathogen Erwinia amylovora.
AID336958Cytotoxicity against human Raji cells assessed as cell viability at 500 molar ratio
AID1464035Antiproliferative activity against human PC3 cells assessed as inhibition of cell growth incubated for 96 hrs by MTT assay2017Bioorganic & medicinal chemistry, 10-15, Volume: 25, Issue:20
Conjugates of 18β-glycyrrhetinic acid derivatives with 3-(1H-benzo[d]imidazol-2-yl)propanoic acid as Pin1 inhibitors displaying anti-prostate cancer ability.
AID1083187Bactericidal activity against Pantoea agglomerans 599 assessed as growth inhibition at pH 7.2 by suspension culture assay2012Journal of agricultural and food chemistry, Dec-12, Volume: 60, Issue:49
Potent and specific bactericidal effect of juglone (5-hydroxy-1,4-naphthoquinone) on the fire blight pathogen Erwinia amylovora.
AID1625337Activation of human TRPA1 expressed in HEK293 cells assessed as increase in calcium level at 20 uM in presence of TRPA1 channel blocker A-967079 by fura2/AM dye based single cell based plate reader analysis2016Journal of natural products, Apr-22, Volume: 79, Issue:4
Plumbagin, Juglone, and Boropinal as Novel TRPA1 Agonists.
AID308235Inhibition of papain at 65 uM after 30 mins2007Bioorganic & medicinal chemistry, Aug-01, Volume: 15, Issue:15
The 1,4-naphthoquinone scaffold in the design of cysteine protease inhibitors.
AID1083196Bactericidal activity against Erwinia amylovora 797 assessed as growth inhibition at pH 7.2 by suspension culture assay2012Journal of agricultural and food chemistry, Dec-12, Volume: 60, Issue:49
Potent and specific bactericidal effect of juglone (5-hydroxy-1,4-naphthoquinone) on the fire blight pathogen Erwinia amylovora.
AID1083191Bactericidal activity against Erwinia amylovora 894 assessed as growth inhibition at pH 7.2 by suspension culture assay2012Journal of agricultural and food chemistry, Dec-12, Volume: 60, Issue:49
Potent and specific bactericidal effect of juglone (5-hydroxy-1,4-naphthoquinone) on the fire blight pathogen Erwinia amylovora.
AID1625342Activation of human TRPA1 expressed in HEK293 cells assessed as induction of inward current at 10 uM at -70 to +70 mV by whole cell patch clamp assay2016Journal of natural products, Apr-22, Volume: 79, Issue:4
Plumbagin, Juglone, and Boropinal as Novel TRPA1 Agonists.
AID1758988Inhibition of DNA topoisomerase 1 (unknown origin)2021Bioorganic & medicinal chemistry letters, 06-01, Volume: 41Synthesis, biological evaluation, and correlation of cytotoxicity versus redox potential of 1,4-naphthoquinone derivatives.
AID1391263Inhibition of human N-terminal His6-tagged Pin1 PPIase activity expressed in Escherichia coli BL21 using Suc-Ala-Glu-cis-Pro-Phe-4-nitroanilide as substrate preincubated for 10 mins followed by substrate addition monitored for 90 secs by protease enzyme c2018Bioorganic & medicinal chemistry, 05-01, Volume: 26, Issue:8
Synthesis and biological evaluation of pyrimidine derivatives as novel human Pin1 inhibitors.
AID1869322Antiproliferative activity against human HCT-116 cells measured after 72 hrs by SRB assay2022Journal of natural products, 06-24, Volume: 85, Issue:6
Identification and Characterization of Natural and Semisynthetic Quinones as Aurora Kinase Inhibitors.
AID1869313Inhibition of Aurora A (122 to 403 residues) (unknown origin) expressed in Escherichia coli Rosetta 2(DE3) assessed as reduction in TACC3 phosphorylation at Ser 558 residue at 25 uM using TACC3 (519 to 838 residues) as substrate measured after 30 mins by 2022Journal of natural products, 06-24, Volume: 85, Issue:6
Identification and Characterization of Natural and Semisynthetic Quinones as Aurora Kinase Inhibitors.
AID752857Induction of apoptosis in human LNCAP cells assessed as activation of caspase-3 and 9 at 15 uM after 24 hrs by Western blot analysis relative to control2013Bioorganic & medicinal chemistry letters, Jun-15, Volume: 23, Issue:12
Juglone, isolated from Juglans mandshurica Maxim, induces apoptosis via down-regulation of AR expression in human prostate cancer LNCaP cells.
AID752851Induction of apoptosis in human LNCAP cells assessed as decrease of DHT-induced androgen receptor mRNA expression at 15 uM treated 2 hrs before DHT challenge measured after 24 hrs by RT-PCR analysis2013Bioorganic & medicinal chemistry letters, Jun-15, Volume: 23, Issue:12
Juglone, isolated from Juglans mandshurica Maxim, induces apoptosis via down-regulation of AR expression in human prostate cancer LNCaP cells.
AID1271955Growth inhibition of human A549 cells by MTT assay2016Bioorganic & medicinal chemistry letters, Jan-15, Volume: 26, Issue:2
Novel juglone and plumbagin 5-O derivatives and their in vitro growth inhibitory activity against apoptosis-resistant cancer cells.
AID1869316Selectivity ratio of IC50 for inhibition of Aurora B (unknown origin) to IC50 for inhibition of Aurora A (unknown origin)2022Journal of natural products, 06-24, Volume: 85, Issue:6
Identification and Characterization of Natural and Semisynthetic Quinones as Aurora Kinase Inhibitors.
AID1271960Cytotoxicity against human U373 cells at 17 uM after 72 hrs by video microscopic analysis2016Bioorganic & medicinal chemistry letters, Jan-15, Volume: 26, Issue:2
Novel juglone and plumbagin 5-O derivatives and their in vitro growth inhibitory activity against apoptosis-resistant cancer cells.
AID1083200Bactericidal activity against Erwinia amylovora 657 assessed as growth inhibition at pH 7.2 by suspension culture assay2012Journal of agricultural and food chemistry, Dec-12, Volume: 60, Issue:49
Potent and specific bactericidal effect of juglone (5-hydroxy-1,4-naphthoquinone) on the fire blight pathogen Erwinia amylovora.
AID1758985Cytotoxicity against human KB cells2021Bioorganic & medicinal chemistry letters, 06-01, Volume: 41Synthesis, biological evaluation, and correlation of cytotoxicity versus redox potential of 1,4-naphthoquinone derivatives.
AID1832334Inhibition of SARS-CoV-2 main protease by tandem mass spectrometry analysis2021European journal of medicinal chemistry, Dec-05, Volume: 225Discovery of juglone and its derivatives as potent SARS-CoV-2 main proteinase inhibitors.
AID336956Inhibition of TPA-induced EBV-early antigen activation in human Raji cells at 10 molar ratio after 48 hrs by indirect immunofluorescence technique relative to TPA
AID1083192Bactericidal activity against Erwinia amylovora 893 assessed as growth inhibition at pH 7.2 by suspension culture assay2012Journal of agricultural and food chemistry, Dec-12, Volume: 60, Issue:49
Potent and specific bactericidal effect of juglone (5-hydroxy-1,4-naphthoquinone) on the fire blight pathogen Erwinia amylovora.
AID1083204Bactericidal activity against Erwinia amylovora 385R assessed as growth inhibition at pH 7.2 by suspension culture assay2012Journal of agricultural and food chemistry, Dec-12, Volume: 60, Issue:49
Potent and specific bactericidal effect of juglone (5-hydroxy-1,4-naphthoquinone) on the fire blight pathogen Erwinia amylovora.
AID1083184Bactericidal activity against Bacillus subtilis NCTC 10315 assessed as growth inhibition at pH 7.2 by suspension culture assay2012Journal of agricultural and food chemistry, Dec-12, Volume: 60, Issue:49
Potent and specific bactericidal effect of juglone (5-hydroxy-1,4-naphthoquinone) on the fire blight pathogen Erwinia amylovora.
AID752861Induction of apoptosis in human LNCAP cells assessed as cell shrinkage at 5 to 15 uM after 24 hrs using Hoechst 33342 staining by fluorescence microscopic analysis2013Bioorganic & medicinal chemistry letters, Jun-15, Volume: 23, Issue:12
Juglone, isolated from Juglans mandshurica Maxim, induces apoptosis via down-regulation of AR expression in human prostate cancer LNCaP cells.
AID417086Inhibition of histidine-tagged human recombinant Cdc25B catalytic domain expressed in Escherichia coli2009Bioorganic & medicinal chemistry, Mar-15, Volume: 17, Issue:6
Bioactivities of simplified adociaquinone B and naphthoquinone derivatives against Cdc25B, MKP-1, and MKP-3 phosphatases.
AID1083206Bactericidal activity against Erwinia amylovora 237R assessed as growth inhibition at pH 7.2 by suspension culture assay2012Journal of agricultural and food chemistry, Dec-12, Volume: 60, Issue:49
Potent and specific bactericidal effect of juglone (5-hydroxy-1,4-naphthoquinone) on the fire blight pathogen Erwinia amylovora.
AID1625344Activation of human TRPA1 expressed in HEK293 cells assessed as induction of inward current at 10 uM at -70 to +70 mV in presence of TRPA1 channel blocker A-967079 by whole cell patch clamp assay2016Journal of natural products, Apr-22, Volume: 79, Issue:4
Plumbagin, Juglone, and Boropinal as Novel TRPA1 Agonists.
AID1083189Bactericidal activity against Erwinia tasmaniensis 37/10 assessed as growth inhibition at pH 7.2 by suspension culture assay2012Journal of agricultural and food chemistry, Dec-12, Volume: 60, Issue:49
Potent and specific bactericidal effect of juglone (5-hydroxy-1,4-naphthoquinone) on the fire blight pathogen Erwinia amylovora.
AID1156522Cytotoxicity against human HT-29 cells assessed as inhibition of cell viability after 48 hrs by MTT assay2014European journal of medicinal chemistry, Aug-18, Volume: 83Synthesis and anticancer activity of some novel 5,6-fused hybrids of juglone based 1,4-naphthoquinones.
AID19630Partition coefficient (logP)1997Journal of medicinal chemistry, Nov-07, Volume: 40, Issue:23
Simple analogues of anthralin: unusual specificity of structure and antiproliferative activity.
AID1869324Antiproliferative activity against human MOLM-13 cells measured after 72 hrs by SRB assay2022Journal of natural products, 06-24, Volume: 85, Issue:6
Identification and Characterization of Natural and Semisynthetic Quinones as Aurora Kinase Inhibitors.
AID627874Inhibition of calf DNA polymerase alpha using poly(dA)/oligo(dT)18 (A/T = 2/1) and dTTP as the DNA template-primer and nucleotide substrate at 10 uM after 60 mins2011Bioorganic & medicinal chemistry, Oct-01, Volume: 19, Issue:19
Inhibitory effect of novel 5-O-acyl juglones on mammalian DNA polymerase activity, cancer cell growth and inflammatory response.
AID152094In vitro antimalarial activity against human malaria parasite, P falciparum (Vietnam Smith strain)1991Journal of medicinal chemistry, May, Volume: 34, Issue:5
Synthesis and antimalarial activity of 2-aziridinyl- and 2,3-bis(aziridinyl)-1,4-naphthoquinonyl sulfonate and acylate derivatives.
AID1083203Bactericidal activity against Erwinia amylovora 513 assessed as growth inhibition at pH 7.2 by suspension culture assay2012Journal of agricultural and food chemistry, Dec-12, Volume: 60, Issue:49
Potent and specific bactericidal effect of juglone (5-hydroxy-1,4-naphthoquinone) on the fire blight pathogen Erwinia amylovora.
AID336959Cytotoxicity against human Raji cells assessed as cell viability at 100 molar ratio
AID1125073Cytotoxicity against human HeLa cells assessed as cell viability after 24 hrs by MTS assay2014European journal of medicinal chemistry, Apr-22, Volume: 77Quinone-carbohydrate nonglucoside conjugates as a new type of cytotoxic agents: synthesis and determination of in vitro activity.
AID1083177Bactericidal activity against Erwinia amylovora 295/93 assessed as growth inhibition at 10 uM preincubated for 1 hr with UV/visible light by suspension culture assay2012Journal of agricultural and food chemistry, Dec-12, Volume: 60, Issue:49
Potent and specific bactericidal effect of juglone (5-hydroxy-1,4-naphthoquinone) on the fire blight pathogen Erwinia amylovora.
AID627875Inhibition of histidine-tagged human DNA polymerase gamma using poly(dA)/oligo(dT)18 (A/T = 2/1) and dTTP as the DNA template-primer and nucleotide substrate at 10 uM after 60 mins2011Bioorganic & medicinal chemistry, Oct-01, Volume: 19, Issue:19
Inhibitory effect of novel 5-O-acyl juglones on mammalian DNA polymerase activity, cancer cell growth and inflammatory response.
AID476713Growth inhibition of human HBL100 cells after 48 hrs by sulforhodamine B assay2010Bioorganic & medicinal chemistry, Apr-01, Volume: 18, Issue:7
Antiproliferative activity of synthetic naphthoquinones related to lapachol. First synthesis of 5-hydroxylapachol.
AID1625345Activation of human TRPA1 expressed in HEK293 cells assessed as induction of outward current at 10 uM at -70 to +70 mV in presence of TRPA1 channel blocker A-967079 by whole cell patch clamp assay2016Journal of natural products, Apr-22, Volume: 79, Issue:4
Plumbagin, Juglone, and Boropinal as Novel TRPA1 Agonists.
AID752860Induction of apoptosis in human LNCAP cells assessed as membrane blebbing at 5 to 15 uM after 24 hrs using Hoechst 33342 staining by fluorescence microscopic analysis2013Bioorganic & medicinal chemistry letters, Jun-15, Volume: 23, Issue:12
Juglone, isolated from Juglans mandshurica Maxim, induces apoptosis via down-regulation of AR expression in human prostate cancer LNCaP cells.
AID308238Inhibition of pig pancreatic elastase2007Bioorganic & medicinal chemistry, Aug-01, Volume: 15, Issue:15
The 1,4-naphthoquinone scaffold in the design of cysteine protease inhibitors.
AID977602Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID1625352Lipophilicity, logP of compound2016Journal of natural products, Apr-22, Volume: 79, Issue:4
Plumbagin, Juglone, and Boropinal as Novel TRPA1 Agonists.
AID1271956Growth inhibition of human MCF7 cells by MTT assay2016Bioorganic & medicinal chemistry letters, Jan-15, Volume: 26, Issue:2
Novel juglone and plumbagin 5-O derivatives and their in vitro growth inhibitory activity against apoptosis-resistant cancer cells.
AID1758987Redox potential of compound in phosphate buffer at pH 7.2 by cyclic voltammetry2021Bioorganic & medicinal chemistry letters, 06-01, Volume: 41Synthesis, biological evaluation, and correlation of cytotoxicity versus redox potential of 1,4-naphthoquinone derivatives.
AID1083175Bactericidal activity against Erwinia amylovora 295/93 assessed as colony growth inhibition at 25 uM at pH 7.2 by plating assay in presence of 0.5 mg/l mushroom tyrosinase2012Journal of agricultural and food chemistry, Dec-12, Volume: 60, Issue:49
Potent and specific bactericidal effect of juglone (5-hydroxy-1,4-naphthoquinone) on the fire blight pathogen Erwinia amylovora.
AID752855Induction of apoptosis in human LNCAP cells assessed as decrease of androgen receptor protein expression after 24 hrs by Western blot analysis2013Bioorganic & medicinal chemistry letters, Jun-15, Volume: 23, Issue:12
Juglone, isolated from Juglans mandshurica Maxim, induces apoptosis via down-regulation of AR expression in human prostate cancer LNCaP cells.
AID1083172Bactericidal activity against Erwinia amylovora 295/93 assessed as growth inhibition applied as spray solution2012Journal of agricultural and food chemistry, Dec-12, Volume: 60, Issue:49
Potent and specific bactericidal effect of juglone (5-hydroxy-1,4-naphthoquinone) on the fire blight pathogen Erwinia amylovora.
AID1083211Bactericidal activity against Erwinia amylovora 295/93 assessed as growth inhibition in King's B full medium measured at pH 7.2 after overnight incubation by suspension culture assay2012Journal of agricultural and food chemistry, Dec-12, Volume: 60, Issue:49
Potent and specific bactericidal effect of juglone (5-hydroxy-1,4-naphthoquinone) on the fire blight pathogen Erwinia amylovora.
AID1083195Bactericidal activity against Erwinia amylovora 846 assessed as growth inhibition at pH 7.2 by suspension culture assay2012Journal of agricultural and food chemistry, Dec-12, Volume: 60, Issue:49
Potent and specific bactericidal effect of juglone (5-hydroxy-1,4-naphthoquinone) on the fire blight pathogen Erwinia amylovora.
AID627878Inhibition of histidine-tagged human DNA polymerase gamma using bovine deoxyribonuclease 1-treated DNA and dNTP as the DNA template-primer and nucleotide substrate at 10 uM after 60 mins2011Bioorganic & medicinal chemistry, Oct-01, Volume: 19, Issue:19
Inhibitory effect of novel 5-O-acyl juglones on mammalian DNA polymerase activity, cancer cell growth and inflammatory response.
AID752856Induction of apoptosis in human LNCAP cells assessed as decrease of mitochondria membrane potential after 24 hrs using rhodamine 123 dye by flow cytometry2013Bioorganic & medicinal chemistry letters, Jun-15, Volume: 23, Issue:12
Juglone, isolated from Juglans mandshurica Maxim, induces apoptosis via down-regulation of AR expression in human prostate cancer LNCaP cells.
AID233179Antioxidant potential was assessed from reducing activity against 2,2,di-phenyl-1-picrylhydrazyl.1997Journal of medicinal chemistry, Nov-07, Volume: 40, Issue:23
Simple analogues of anthralin: unusual specificity of structure and antiproliferative activity.
AID1181941Time dependent inhibition of recombinant Clostridium botulinum neurotoxin serotype A light chain assessed as Kinact to KI ratio at 200 uM by SNAPtide FRET based assay2014Bioorganic & medicinal chemistry, Aug-01, Volume: 22, Issue:15
Benzoquinones as inhibitors of botulinum neurotoxin serotype A.
AID1507435Antitrypanosomal activity against bloodstream forms of Trypanosoma cruzi Y isolated from parasite infected Albino Swiss mouse assessed as induction of parasite lysis incubated for 24 hrs by Neubauer chamber based cell counting method2017European journal of medicinal chemistry, Aug-18, Volume: 136Rhodium-catalyzed C-H bond activation for the synthesis of quinonoid compounds: Significant Anti-Trypanosoma cruzi activities and electrochemical studies of functionalized quinones.
AID1083201Bactericidal activity against Erwinia amylovora 627 assessed as growth inhibition at pH 7.2 by suspension culture assay2012Journal of agricultural and food chemistry, Dec-12, Volume: 60, Issue:49
Potent and specific bactericidal effect of juglone (5-hydroxy-1,4-naphthoquinone) on the fire blight pathogen Erwinia amylovora.
AID1832337Inhibition of SARS-CoV-2 main protease at 0.1 uM relative to control2021European journal of medicinal chemistry, Dec-05, Volume: 225Discovery of juglone and its derivatives as potent SARS-CoV-2 main proteinase inhibitors.
AID763579Cytotoxicity against human MDA-MB-231 cells assessed as growth inhibition after 72 hrs by MTS assay2013Bioorganic & medicinal chemistry, Aug-01, Volume: 21, Issue:15
Anticancer activity and SAR studies of substituted 1,4-naphthoquinones.
AID627980Cytotoxicity against mouse RAW264.7 cells at 5 uM2011Bioorganic & medicinal chemistry, Oct-01, Volume: 19, Issue:19
Inhibitory effect of novel 5-O-acyl juglones on mammalian DNA polymerase activity, cancer cell growth and inflammatory response.
AID475505Binding affinity to amyloid beta (1 to 42) oligomers by change in fluorescence at 100 uM after 10 mins2009Bioorganic & medicinal chemistry letters, Sep-01, Volume: 19, Issue:17
A chemical screening approach reveals that indole fluorescence is quenched by pre-fibrillar but not fibrillar amyloid-beta.
AID1271959Growth inhibition of human U373 cells by MTT assay2016Bioorganic & medicinal chemistry letters, Jan-15, Volume: 26, Issue:2
Novel juglone and plumbagin 5-O derivatives and their in vitro growth inhibitory activity against apoptosis-resistant cancer cells.
AID1083186Bactericidal activity against Erwinia piriflorinigrans 5888 assessed as growth inhibition at pH 7.2 by suspension culture assay2012Journal of agricultural and food chemistry, Dec-12, Volume: 60, Issue:49
Potent and specific bactericidal effect of juglone (5-hydroxy-1,4-naphthoquinone) on the fire blight pathogen Erwinia amylovora.
AID1125077Ratio of IC50 to INCC50 for human HeLa cells2014European journal of medicinal chemistry, Apr-22, Volume: 77Quinone-carbohydrate nonglucoside conjugates as a new type of cytotoxic agents: synthesis and determination of in vitro activity.
AID1594071Inhibition of recombinant human Pin1 (Met1 to Glu163 residues) expressed in Escherichia coli using Suc-Ala-Glu-cis-Pro-Phe-4-nitroanilide as substrate preincubated for 30 mins followed by substrate addition and measured for 90 secs by protease-coupled ass2019Bioorganic & medicinal chemistry letters, 07-15, Volume: 29, Issue:14
Design, synthesis and biological evaluation of benzimidazole derivatives as novel human Pin1 inhibitors.
AID1181943Glutathione reactivity at 1 mM in presence of 1 mM glutathione containing PBS and 1 mM EDTA buffer at pH 7.4 assessed as remaining GSH level after 10 seconds by spectrophotometry by Ellman's method2014Bioorganic & medicinal chemistry, Aug-01, Volume: 22, Issue:15
Benzoquinones as inhibitors of botulinum neurotoxin serotype A.
AID1156516Cytotoxicity against human ME180 cells assessed as inhibition of cell viability after 48 hrs by MTT assay2014European journal of medicinal chemistry, Aug-18, Volume: 83Synthesis and anticancer activity of some novel 5,6-fused hybrids of juglone based 1,4-naphthoquinones.
AID322955Inhibition of synthetic amyloid beta-42 oligomerization by ELISA2007The Journal of biological chemistry, Apr-06, Volume: 282, Issue:14
Small molecule inhibitors of aggregation indicate that amyloid beta oligomerization and fibrillization pathways are independent and distinct.
AID1083198Bactericidal activity against Erwinia amylovora 792 assessed as growth inhibition at pH 7.2 by suspension culture assay2012Journal of agricultural and food chemistry, Dec-12, Volume: 60, Issue:49
Potent and specific bactericidal effect of juglone (5-hydroxy-1,4-naphthoquinone) on the fire blight pathogen Erwinia amylovora.
AID1083205Bactericidal activity against Erwinia amylovora 363 assessed as growth inhibition at pH 7.2 by suspension culture assay2012Journal of agricultural and food chemistry, Dec-12, Volume: 60, Issue:49
Potent and specific bactericidal effect of juglone (5-hydroxy-1,4-naphthoquinone) on the fire blight pathogen Erwinia amylovora.
AID1083197Bactericidal activity against Erwinia amylovora 793 assessed as growth inhibition at pH 7.2 by suspension culture assay2012Journal of agricultural and food chemistry, Dec-12, Volume: 60, Issue:49
Potent and specific bactericidal effect of juglone (5-hydroxy-1,4-naphthoquinone) on the fire blight pathogen Erwinia amylovora.
AID752863Antiproliferative activity against human LNCAP cells after 24 hrs by MTT assay2013Bioorganic & medicinal chemistry letters, Jun-15, Volume: 23, Issue:12
Juglone, isolated from Juglans mandshurica Maxim, induces apoptosis via down-regulation of AR expression in human prostate cancer LNCaP cells.
AID417089Antiproliferative activity against human A2780 cells after 2 days by alamar-blue assay2009Bioorganic & medicinal chemistry, Mar-15, Volume: 17, Issue:6
Bioactivities of simplified adociaquinone B and naphthoquinone derivatives against Cdc25B, MKP-1, and MKP-3 phosphatases.
AID1175274Inhibition of Pin1 (unknown origin) using Suc-Ala-Glu-Pro-Phe-4-nitroanilide as substrate after 30 mins by protease-coupled assay2014Bioorganic & medicinal chemistry letters, Dec-15, Volume: 24, Issue:24
Synthesis of the novel elemonic acid derivatives as Pin1 inhibitors.
AID1083208Bactericidal activity against Erwinia amylovora 295/93 assessed as growth inhibition at pH 4.5 after overnight incubation by suspension culture assay2012Journal of agricultural and food chemistry, Dec-12, Volume: 60, Issue:49
Potent and specific bactericidal effect of juglone (5-hydroxy-1,4-naphthoquinone) on the fire blight pathogen Erwinia amylovora.
AID475504Binding affinity to amyloid beta (1 to 42) fibrils by change in fluorescence at 100 uM after 10 mins2009Bioorganic & medicinal chemistry letters, Sep-01, Volume: 19, Issue:17
A chemical screening approach reveals that indole fluorescence is quenched by pre-fibrillar but not fibrillar amyloid-beta.
AID1125110Inhibition of p53-dependent transcriptional activity in tumor promotion-sensitive mouse JB6 Cl41 cells after 12 hrs by luciferase-based method2014European journal of medicinal chemistry, Apr-22, Volume: 77Quinone-carbohydrate nonglucoside conjugates as a new type of cytotoxic agents: synthesis and determination of in vitro activity.
AID1125075Cytotoxicity against tumor promotion-sensitive mouse JB6 Cl41 cells assessed as cell viability after 48 hrs by MTS assay2014European journal of medicinal chemistry, Apr-22, Volume: 77Quinone-carbohydrate nonglucoside conjugates as a new type of cytotoxic agents: synthesis and determination of in vitro activity.
AID476712Growth inhibition of human A2780 cells after 48 hrs by sulforhodamine B assay2010Bioorganic & medicinal chemistry, Apr-01, Volume: 18, Issue:7
Antiproliferative activity of synthetic naphthoquinones related to lapachol. First synthesis of 5-hydroxylapachol.
AID1420356Antiproliferative activity against human PC3 cells after 96 hrs by MTT assay2018Bioorganic & medicinal chemistry letters, 10-15, Volume: 28, Issue:19
Design, synthesis and biological evaluation of ring A modified 11-keto-boswellic acid derivatives as Pin1 inhibitors with remarkable anti-prostate cancer activity.
AID1083194Bactericidal activity against Erwinia amylovora 871 assessed as growth inhibition at pH 7.2 by suspension culture assay2012Journal of agricultural and food chemistry, Dec-12, Volume: 60, Issue:49
Potent and specific bactericidal effect of juglone (5-hydroxy-1,4-naphthoquinone) on the fire blight pathogen Erwinia amylovora.
AID763578Cytotoxicity against human HT-29 cells assessed as growth inhibition after 72 hrs by MTS assay2013Bioorganic & medicinal chemistry, Aug-01, Volume: 21, Issue:15
Anticancer activity and SAR studies of substituted 1,4-naphthoquinones.
AID1181940Irreversible inhibition of recombinant Clostridium botulinum neurotoxin serotype A light chain assessed as Kinact to KI ratio after 1.5 hrs by SNAPtide FRET based assay2014Bioorganic & medicinal chemistry, Aug-01, Volume: 22, Issue:15
Benzoquinones as inhibitors of botulinum neurotoxin serotype A.
AID627876Inhibition of C-terminal His6-tagged human DNA polymerase kappa (amino acids 1 to 560) using poly(dA)/oligo(dT)18 (A/T = 2/1) and dTTP as the DNA template-primer and nucleotide substrate at 10 uM after 60 mins2011Bioorganic & medicinal chemistry, Oct-01, Volume: 19, Issue:19
Inhibitory effect of novel 5-O-acyl juglones on mammalian DNA polymerase activity, cancer cell growth and inflammatory response.
AID501586Antiparasitic activity against Trichomonas vaginalis G3 at 100 uM after 24 hrs by hemocytometric analysis2010Bioorganic & medicinal chemistry letters, Sep-01, Volume: 20, Issue:17
Preliminary studies of 3,4-dichloroaniline amides as antiparasitic agents: structure-activity analysis of a compound library in vitro against Trichomonas vaginalis.
AID476714Growth inhibition of human HeLa cells after 48 hrs by sulforhodamine B assay2010Bioorganic & medicinal chemistry, Apr-01, Volume: 18, Issue:7
Antiproliferative activity of synthetic naphthoquinones related to lapachol. First synthesis of 5-hydroxylapachol.
AID1869323Antiproliferative activity against human MCF7 cells measured after 72 hrs by SRB assay2022Journal of natural products, 06-24, Volume: 85, Issue:6
Identification and Characterization of Natural and Semisynthetic Quinones as Aurora Kinase Inhibitors.
AID1594144Inhibition of Escherichia coli GroEL expressed in Escherichia coliDH5alpha/Escherichia coli GroES expressed in Escherichia coli BL21 (DE3) assessed as reduction in GroEL/GroES-mediated denatured soluble pig heart MDH refolding by measuring MDH enzyme acti2019Bioorganic & medicinal chemistry letters, 05-01, Volume: 29, Issue:9
HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules.
AID1271954Growth inhibition of human Hs683 cells by MTT assay2016Bioorganic & medicinal chemistry letters, Jan-15, Volume: 26, Issue:2
Novel juglone and plumbagin 5-O derivatives and their in vitro growth inhibitory activity against apoptosis-resistant cancer cells.
AID627880Inhibition of recombinant His-tagged human DNA polymerase lambda using bovine deoxyribonuclease 1-treated DNA and dNTP as the DNA template-primer and nucleotide substrate at 10 uM after 60 mins2011Bioorganic & medicinal chemistry, Oct-01, Volume: 19, Issue:19
Inhibitory effect of novel 5-O-acyl juglones on mammalian DNA polymerase activity, cancer cell growth and inflammatory response.
AID588519A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities2011Antiviral research, Sep, Volume: 91, Issue:3
High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors.
AID540299A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis2010Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).2014Journal of biomolecular screening, Jul, Volume: 19, Issue:6
A High-Throughput Assay to Identify Inhibitors of the Apicoplast DNA Polymerase from Plasmodium falciparum.
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).
AID1159607Screen for inhibitors of RMI FANCM (MM2) intereaction2016Journal of biomolecular screening, Jul, Volume: 21, Issue:6
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
AID977610Experimentally measured binding affinity data (Ki) for protein-ligand complexes derived from PDB2008Acta pharmacologica Sinica, Jul, Volume: 29, Issue:7
Natural product juglone targets three key enzymes from Helicobacter pylori: inhibition assay with crystal structure characterization.
AID1159550Human Phosphogluconate dehydrogenase (6PGD) Inhibitor Screening2015Nature cell biology, Nov, Volume: 17, Issue:11
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (343)

TimeframeStudies, This Drug (%)All Drugs %
pre-199020 (5.83)18.7374
1990's18 (5.25)18.2507
2000's75 (21.87)29.6817
2010's170 (49.56)24.3611
2020's60 (17.49)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 60.82

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index60.82 (24.57)
Research Supply Index5.89 (2.92)
Research Growth Index5.12 (4.65)
Search Engine Demand Index101.71 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (60.82)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews8 (2.23%)6.00%
Case Studies4 (1.11%)4.05%
Observational0 (0.00%)0.25%
Other347 (96.66%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]